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ABSTRACT
Chicl( brain growth factor (CBGF) is a mitogen isolated from
embryonic chick brains thought to have a potential role as a trophic factor
involved in nerve dependent amphibian limb regeneration. In addition,
CBGF stimulates 3H-thymidine incorporation in chick embryo brain
astrocytes in vitro.
In this study, cultured chick embryo brain non-neuronal cells were
employed in a bioassay to monitor CBGF activity throughout various stages
of its pllrification. Cell culture and assay conditions were optimized. Non-
neuronal cells grew best on collagen-coated culture dishes in complete
medium, were most responsive to a growth stimulus [10% fetal bovine
serum (FBS)] at the second and third subcultures, and were healthiest
when rendered "quiescent" in medium supplemented with 1% FBS. The
most effective bioassay conditions consisted of a minimum 14.5 hour
"quiescence" time (24 hours was used), a 6 hour "prestimulation" time, and
a 24 hour 3H-thymidine labeling time. Four-day subconfluent primary
non-neuronal cells consisted of 6.63% GFAP positive cells; as a result
cultures were thought to be mainly composed of astroblasts.
CBGF was purified from 18-day chick embryo brains by
ultrafiltration through Amicon PM-30 and YM-2 membranes, size exclusion
chromatography through a Biogel P6 column, and analytical reverse-phase
high-performance liquid chromatography (rp-HPLC). The greatest activity
resided in rp-HPLC fraction #7 (10 ng/ml) which was as effective as 10%
FBS at stimulating 3H-thymidine incorporation in chick embryo brain non-
neuronal cells.
Although other researchers report the isolation of a mitogenic
fraction consisting of 5'-GMP from the embryonic chick brain, UV
absorbance spectra, rp-HPLC elution profiles, and fast atom bombardment
(FAB) mass spectra indicated that CBGF is neither 5'-GMP nor 5 1-AMP.
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Moreover, commercially available 5t -GMP was inhibitory to 3H-thymidine
incorporation in the chick non-neuronal cells, while Sf-AMP had no effect.
Upon treatment with pronase, the biological activity of fraction P6-3
increased; this increase was nearly 30% greater than what would be
expected from a simple additive effect of any mitogenic activity of pronase
alone together with P6-3 alone. This may suggest the presence of an
inhibitor protein. The bioactive component may be a protein protected by
a nucleoside/nucleotide or simply a nucleoside/nucleotide acting alone.
While the FAB mass spectrum of rp-HPLC fraction #7 did not reveal
molecular weight or sequence information, the ion of highest molecular
weight was observed at m/z 1610; this is consistent with previous
estimations of CBGF's size.
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INTRODUCTION
Chick brain growth factor (CBGF), a mitogen isolated from 18 day
chick embryo brains, is one of several trophic factors proposed to have a
role in blastema cell proliferation during the nerve dependent stages of
amphibian limb regeneration (Carlone and Rathbone, 1985; Carlone et ai.,
1987). This supposition is based upon the fact that CBGF (10 ng/ml) has a
mitogenic effect on cultured blastema explants from forelimb regenerates
of the adult newt Notophthalmus viridescens (Carlon-e et al., 1987) and on
mesenchyme-like cells of Xenopus laevis limb regenerates (Tsilfidis and
Liversage, 1989). Moreover, CBGF activity lacks species specificity, since a
fraction isolated from adult newt brains has identical biochemical
characteristics as CBGF and is mitogenic for newt blastema cells (Carlone e t
al., 1987).
CBGF has been purified to apparent homogeneity by ultrafiltration
through Amicon PM-3D, YM-2, and UM-05 membranes, DEAE ion-exchange
chromatography, and reverse-phase high-performance liquid
chromatography (rp-HPLC) (Carlone and Rathbone, 1985; Carlone et al.,
1987). In addition to its effect on newt blastemas and Xenopus
regenerates, CBGF also stimulates 3H-thymidine incorporation in 10 day
chick embryo brain astrocytes and Swiss mouse 3T3 fibroblasts (Carlone
and Rathbone, 1985; Carlone et al., 1988).
The loss of biological activity which occurs when CBGF is incubated
with either trypsin (Carlone and Rathbone, 1985) or pronase, in contrast to
its stability upon treatment with RNase and DNase (Carlone, unpublished
results) suggests that the factor is a peptide. Amino acid analysis has
revealed that CBGF is a small polar peptide of 15 amino acids (Carlone e t
al., 1987). This evidence, in addition to the HPLC retention time, the SDS-
polyacrylamide gel electrophoresis mobility (dansylated peptides), and
preliminary mass spectrometry data" has approximated the molecular
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weight of CBGF at 1,500-1,600 Da (Carlone et al., 1987; Carlone,
unpublished results). Other researchers have also isolated astrocyte
mitogens from the 18 day chick embryo brain using a slightly different
procedure than that used to purifyCBGF; the most active fraction was
determined to be guanosine 5'-monophosphate (5'-GMP) (Kim et al., 1991)
with less potent activities residing in a fraction composed of adenosine
5'-monophosphate (Rathbone et al., 1992a) and other unidentified
fractions (Rathbone et al., 1992b).
The bioassay employed to assess CBGF's mitogenic activity at various
stages of purification monitors its ability to promote 3H-thymidine
incorporation into chick embryo brain astoblasts/astrocytes in vitro
(Carlone et al., 1987). Because they had not been previously optimized, the
first goal of this research was to determine the most effective cell culture
conditions and bioassay parameters.
The protocol used to isolate CBGF involved ultrafiltration through a
series of Amicon filters of decreasing porosity, with the active fraction
being retained on a type UM-05 membrane with a nominal molecular
weight cut-off of 500 Da (Carlone et al., 1987). When the manufacture of
this membrane was ceased, it was no longer possible to obtain a
biologically active retentate from the replacement membrane, YC-05
(Carlone, personal communication). Furthermore, because CBGF was found
to be a polar molecule, the inclusion of anion exchange chromatography In
the isolation scheme might aid in separation of a more highly purified
CBGF. Therefore, the second goal of this thesis was to improve the isolation
and purification procedure of CBGF.
As previously stated, earlier studies suggested that CBGF is a small
peptide of 1,500-1,600 Da (Carlone et aI., 1987). Moreover, other
researchers had isolated 5'-GMP and 5'-AMP as astrocyte mitogens from
the 18 day chick embryo brain (Kim et al., 1991; Rathbone et al., 1992a).
On the other hand, while a CBGF fraction obtained from Rathbone and his
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colleagues was found to contain 5'-GMP, it did not stimulate 3H-thymidine
incorporation into chick astrocytes; interestingly, preliminary nuclear
magnetic resonance (NMR) studies indicated the presence of
nucleosides/nuceotides in inactive rp-HPLC fractions and their absence in
mitogenic fractions (M.Seifried, honours thesis, 1988). Thus, the third goal
of this research was to further characterize CBGF's biochemical properties
and to reconcile the contradictory results which have been described.
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LITERATURE REVIEW
Growth Factors
The term growth factor has traditionally been used to refer to a
peptide or protein that has a potent proliferative effect on certain cell
types. In vitro, they stimulate DNA synthesis and mitosis by promoting
movement through the cell cycle and so have been employed in the
maintenance of cultured cells (Brockes, 1984).
However, research on the burgeoning number of factors being found
has indicated that they can have far more diverse functions. More than
simple mitogens, some growth factors can have an inhibitory rather than
stimulatory effect on cell proliferation (Sporn and Roberts, 1988).
Moreover, these molecules have also been seen to guide morphogenesis
and to induce differentiation in some systems (Mercola and Stiles, 1988).
In addition, some factors promote cell survival (Logan, 1990). Growth
factors can also affect other aspects of cell function seemingly unrelated to
these; for example, epidermal growth factor (EGF) suppresses gastric acid
secretion (Gregory, 1975), while interleukin-6 (IL-6) increases secretion of
immunoglobulins (Kishimoto and Hirano, 1988). Contributing to the
complexity of this subject is the fact that many neuropeptides have been
shown to be slow-acting mitogens in addition to their roles as fast-acting
neurotransmitters and hormones (Woll and Rozengurt, 1989).
Another complicating factor is that growth factors may be deployed
in three distinct delivery mechanisms. In the autocrine method, cells
produce growth factors for which they themselves have receptors and to
which they respond. Paracrine growth factors, on the other hand, are
made in one cell type and act upon their receptors in a nearby, but
different cell type. Alternatively, the factor may be distributed through
the circulation to distant cells in an endocine manner (Waterfield, 1989).
1 5
While growth factors may have various functions and identities, they
can also have a broad range of cells for which they are biologically active.
An example is provided by transforming growth factor-beta (TGF-~) which
is mitogenic for both fibroblasts and osteoblasts, while being anti-
proliferative for epithelial cells, T-lymphocytes, and fibroblasts and
osteoblasts under other circumstances (Sporn and Roberts, 1988). The
presence of other growth factors can profoundly alter the effect a given
factor has on its target. This is the case with TGF-f3 which, in the presence
of platelet-derived growth factor (PDGF), stimulates the growth of some
fibroblasts in vitro, while inhibiting their growth when EGF is present
(Roberts et al., 1985). The differentiative state of a cell also appears to
influence the actions of growth factors on it (Sporn and Roberts, 1988).
Out of all this confusion, researchers are trying to find a common
thread with which to pull all these disparate functions and details together.
One simplification has been the discovery that growth factors may be
organized into superfamilies, groupings which are based upon nucleotide
and amino acid sequence homology in addition to similar receptor-binding
activity (Mercola and Stiles, 1988). Thus, for example, the transforming-
growth factor-beta family has several members, including: TGF- f31,
TGF- f12, TGF- f31,2, inhibin-A, inhibin-B, activin-A, activin AB, the
Mullerian-inhibiting substance (MIS) (Mercola and Stiles, 1988) and the
bone morphogenic proteins (BMPs - with the exception of BMP-1) (Celeste
et al., 1990).
While growth factors from differing superfamilies may lack
significant overall sequence similarity, aspects of their three-dimensional
structure may be conserved indicating their evolutionary relatedness
(McDonald and Hendrickson, 1993). For example, while NGF, TGFf3, PDGF,
and their families have distinct biological roles, they belong to a structural
superfamily which shares a "cystine knot" motif and a conserved ~-strand
structure (McDonald and Hendrickson, 1993).
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Another feature some growth factors have in common is the action of
the receptor to which they bind and begin to mediate their response. The
receptors for BGF, PDGF, insulin and insulin-like growth factor I (IGF-I)
function as tyrosine-specific protein kinases, phosphorylating protein
"second messengers" intracellularly in response to the factor binding to the
extracellular domain of the membrane-spanning receptor (Mercola and
Stiles, 1988; Bender, 1985).
While growth factors can induce lineage-specific genes, that is one
mitogen may stimulate the expression of different genes in differing cell
types, they also evoke the expression of the same sets of genes in various
tissues. These genes include several proto-oncogenes, among them c - my c
and c-fos which respond to, for example, BOF, PDGF, and nerve growth
factor (NGF) (Woodgett, 1989). The products of genes such as c-myc and
c-fos may generate a general growth factor response, the specific nature of
which is dependent not only on cell type, but also the differentiative state
of the cell. Therefore, it is possible to explain the pleiotropic effects of
growth factors using a mechanism in which a common switch is employed
by many cell types to yield numerous varying responses (Mercola and
Stiles, 1988). Such a common switch points to a conserved signalling
scheme that may also be present in the homeotic pattern-forming loci
Notch in Drosophila and lin-12 in Caenorhabditis elegans. This could
explain the observed homology between the protein products of these
genes and BOF (Bender, 1985).
Another piece in the puzzle is a potential link between
differentiation and cell cycle control. With the exception of aspects of
embryonic development, proliferation and differentiation seem to be
mutually exclusive. Perhaps a simple binary on/off switch to cell division
is activated by growth factors to release or arrest the cell cycle and to
ultimately control differentiation (Mercola and Stiles, 1988).
One unifying view of the complexities of growth factors has been to
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envision them as characters in the alphabet of a cellular signalling
language which convey their information via patterns rather than as
individuals. Redundancy in the effects of the factors may represent a
precaution used to avoid errors in signal transmission (Sporn and Roberts,
1988).
Nerve Dependent Limb Regeneration
A . The events of normal regeneration
Epimorphic limb regeneration is a remarkable ability possessed
exclusively by larval and adult urodele amphibians such as newts,
salamanders, axolotls, and the tadpole larvae of frogs and toads. Although
these are the only vertebrates able to regenerate a limb or tail, all
vertebrates are capable of tissue repair to, for example, epithelia, bone,
liver, and muscle (Wallace, 1981). Some researchers argue that the
cartilaginous spike characteristic of postmetamorphic Xenopus
regeneration represents a transitional stage between complete epimorphic
regeneration and simple tissue repair (Goss and Holt, 1992). Following
amputation, normal regeneration ensues, beginning with the rapid
migration of epidermal cells to cover the wound within a few hours. This
migration continues, and the wound epithelium thickens, largely without
concomittant local mitosis, to form the apical epidermal cap (Repesh and
Oberpriller, 1980). The specialized wound epithelium of the regenerate
differs from that encountered during normal wound healing since it lacks a
basement membrane, thereby coming into direct contact with underlying
tissues; in fact, without this immediate contact, regeneration is prevented.
Underneath this epithelial jacket, undifferentiated mesenchymal
progenitor cells migrate from the stump mesoderm to form a local growth
zone known as the blastema (Singer, 1978; Wallace, 1981; Brockes, 1987a).
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The issue as to whether blastema cells originate from reserve cells
(Cameron et al., 1986) or by dedifferentiation from various adult tissues
(Casimir et al., 1988) remains unresolved. However, recent findings
demonstrate that multinucleate myotubes implanted into the limb
blastema are induced to dedifferentiate into mononucleate cells which
proliferate; limited evidence indicates that these cells subsequently
redifferentiated, with some undergoing metaplasia (Lo et al., 1993). The
epidermal cells do not appear to contribute to the cells of the blastema and
the reverse apparently also holds true (Chalkley, 1954; Hay and Fischman,
1961; O'Steen and Walker, 1961). The distally migrating blastema cells
commence cell division 3-5 days after amputation and continue rapid
proliferation for 2-3 weeks giving rise to a protruding cone of cells. The
cells subsequently form into a flattened palette shape and begin to display
the characteristic protrusions that further elongate to become the digits
(Wallace, 1981). During this period, the blastema redifferentiates in a
proximal to distal sequence, and undergoes morphogenesis, thereby
reconstructing the necessary cartilage, muscle, and connective tissues of
the regenerate limbs. The wound epithelium is thought to have a role in
cell proliferation, the maintenance of a gradient of mesenchyme
differentiation, and the direction of regenerate outgrowth (Wallace, 1981).
In the adult newt, the final functional and normally sized replacement is
completed after approximately five weeks, virtually irrespective of where
along the proximal-distal axis amputation occurred (Brockes, 1987a).
B. The nerve dependence of regeneration
Regeneration, and in particular, early blastema cell proliferation, is
under the influence of peripheral nerves having axons present at the
amputation plane (Todd, 1823; Singer, 1952; 1978; Brockes, 1984; 1987a).
If the limb is denervated prior to amputation, the early non-proliferative
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events of regeneration take place: the wound epidermis forms and the
first blastema cells arise from the mesoderm; however, the usual onset of
blastema cell division is prevented, as evidenced by the eventual decrease
in both the 3H-thymidine labelling index and mitotic index (Singer and
Craven, 1948; Maden, 1978). The synthesis of RNA and protein are also
curtailed. Thus, it appears that denervation dramatically retards cell cycle
activity (Wallace,1981).
Although it is debated as to whether denervation callses blastema
cells to block in Gl or G2 of the cell cycle, recent evidence tends to support
the hypothesis of a blockage in Gl (Oudld1ir et ai., 1985; Tassava et al.,
1987; Goldhamer and Tassava, 1987) with some cells prematurely exiting
the cell cycle into the Go phase (Boilly et ai., 1986). The "punctuated"
cycling phenomenon, suggested by Tomlinson et ala (1985), proposes the
existence of at least two blastema cell subpopulations, an actively cycling
population and a transiently quiescent population, which compose the
proliferative fraction of the blastema; nerves appear to act primarily in Gl
by controlling the entry of transiently quiescent cells into the actively
cycling population (Goldhamer and Tassava, 1987). Denervated and
amputated axolotl limbs exhibit reductions in the size of the proliferative
and actively cycling fractions of the blastema cell population with
prolonged denervation, while innervated limbs display an increase in the
actively cycling population, at the expense of transiently quiescent cells,
during the period of rapid blastemal growth (Tomlinson and Barger, 1987).
Immediately following denervation, there is an initial burst of DNA,
RNA, and protein syntheses, as well as an increase in the number of
mitoses. This observation, in combination with the later effects of
denervation, suggest that the nerves release a trophic factor which
stimulates the cell cycle and promotes blastema cell proliferation (Singer,
1974; 1978; Brockes, 1984; 1987a). Cutting of the nerve, as in
denervation, apparently causes an initial rapid discharge of the trophic
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substance from the degenerating axons, after which no replenishing source
of the factor exists. Consequently, the blastema does not grow, the
subsequent events of regeneration do not take place, and formation of the
regenerate ceases.
When denervation is postponed for up to approximately 14 days
following amputation, blastema cell proliferation drops markedly and
regeneration stops, with the blastema being converted into fibrocellular
tissue and cartilage (Singer, 1978). After this point, however, when the
blastema has reached the palette stage, a critical mass of blastema cells has
formed since denervation causes a less severe decrease in the mitotic
index and a normal, albeit smaller, limb is formed. Therefore, while the
nerve and its putative trophic factor control progenitor cell proliferation
during the first two weeks following amputation, they have no bearing on
the nature of the structure formed (Singer, 1978; Wallace, 1981).
Extensive studies of newt forelimb innervation density and
regeneration were conducted by Singer (1952; 1974). He found that the
forelimb of the adult newt is innervated by the third, fourth, and fifth
spinal nerves which merge at the brachial plexus before dividing and
entering the limb; the forelimb is also innervated by a minor sympathetic
component. The density and type of innervation, be it motor or sensory,
may be varied by cutting the distal axons and allowing them to
degenerate, leaving the denervated Schwann cell sheaths in their wake. In
this way, it was possible to demonstrate that there exists a quantitative
relationship between the density of innervation at the amputation surface
and the frequency of regeneration (Singer, 1947). However, Singer's
hypothesized threshold innervation density absolutely required for
regeneration to take place does not seem to be a valid assumption since
other researchers have found no evidence for such a limiting value
(Karczmar, 1946; Wallace, 1981); in fact, regeneration can occur even in
the total absence of nerves in the special circumstance of the aneurogenic
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limb (to be described in detail later) (Yntema, 1959a,b). Moreover, not
only is the frequency of regeneration directly proportional to the available
nerve supply, but it is independent of whether the innervation is
exclusively of a motor or a sensory nature (Sidman and Singer, 1960). In
addition, regeneration can take place as long as the axons at the cut site
remain intact with their cell bodies; a complete pathway to the central
nervous system is not necessary. This further seems to indicate the
involvement of an axonally transmitted factor, which does not seem to
require involvement of Schwann and connective tissue sheath cells
(Wallace, 1981). However, nerve augmentation by implantation of dorsal
root ganglia into normally innervated newt blastemas does not cause an
increase in cell cycle activity, indicating that levels of the nerve's trophic
factor are not quantitatively limiting and are not responsible for the
relatively small actively cycling cell population of the adult newt blastema
(Goldhamer et al., 1992).
Interestingly, previously injured axons regenerate more rapidly than
than those only subjected to a testing lesion and concomitantly cause
accelerated limb regeneration in vivo (Maier et al., 1984); regrowing
nerves also demonstrate enhanced mitogenicity for newt blastemas i n
vitro (Boilly and Bauduin, 1988).
c. A nerve dependent subpopulation of blastema cells
The question as to whether the undifferentiated mesenchymous cells
of the blastema are an homogeneous population or whether they are
composed of molecularly disparate cells has been addressed by Brockes
and his colleagues (Brockes, 1984; 1987a; 1991). They immunized mice
with early forelimb blastemas from the newt and screened the antibody-
secreting clones by immunofluorescence on sections of the early limb
regenerate; the 22/18 antibody was the only one isolated which
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differentiated between blastema cells and those of the unamputated limb,
preferentially labelling the progenitor cells of the regenerate (Kintner and
Brockes, 1984; 1985).
In regenerating tissue, the 22/18 antigen is a cytoskeletal
component, apparently a conformational determinant on intermediate
filaments as evidenced by the intracellular, filamentous staining pattern
seen in 22/18 immunoreactive cells (Fekete et al., 1987; Ferretti and
Brockes, 1990). The expression of the 22/18 antigen begins within 36-48
hours after amputation and is initially confined to non-neural, non-muscle
interstitial cells of a bipolar or dendritic morphology; this cell type is
located throughout injured tissues such as nerve, muscle, and dermis
(Gordon and Brockes, 1988). These cells may represent a type of reserve
cell that makes an early contribution to the blastema. The 22/18 + cells
sometimes observed in intact healthy newt limbs had a similar
morphology and interstitial location as that seen for regenerating tissue,
but displayed a granular, as opposed to filamentous staining pattern. This
complementary distribution points to a potential role for granular-staining
22/18 + cells of the normal limb as precursors to the filamentous-staining
22/18 + cells of regenerating tissue (Gordon and Brockes, 1988). The early
appearance of 22/18 + cells occurs prior to DNA synthesis and proliferation
of the blastema cells, indicating that expression of the antigen is not
induced by mitosis. Four to five days post-amputation, expression of the
22/18 antigen is also observed in Schwann cells of the nerve sheath, but is
not seen in axons or in fibroblasts (Kintner and Brockes, 1984; 1985).
Anatomical studies have also suggested that Schwann cells may contribute
to the blastema following dedifferentiation (Brockes, 1984). After about
twelve days, it is clear that muscle cells also contribute to the blastema,
since cells that stain with both the 22/18 and a myofiber-specific antibody
can be seen (Kintner and Brockes, 1984). Incidentally, such double-
labelled cells may represent intermediates in dedifferentiation,
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temporarily displaying properties of differentiated parent cells and
blastema cells. Cells with this staining pattern reappear about three weeks
after amputation as blastema cells begin to redifferentiate into muscle cells
(Brockes, 1984). More evidence for dedifferentiation and metaplasia
comes from studies using DNA hypomethylations as lineage markers to
follow cells fates during limb regeneration (Casimir et aI., 1988); such
investigations have suggested that cells from muscle and connective tissue
lineages contribute to the cartilage of the regenerate.
In the two weeks following amputation, approximately 80% of
blastema cells react with the 22/18 antibody. However, in the following
week, 14-21 days after amputation, the differentiating blastema cells
progressively begin to lose reactivity with the antibody (Kintner and
Brockes, 1985). The fully differentiated regenerate, like the normal
unamputated limb, is essentially 22/18 -. Moreover, 22/18 expression is
not a transient response to injury, but a stable one, as evidenced by its
continued expression even when regeneration is blocked in vivo (Fekete e t
al., 1.987; Gordon and Brockes, 1988). Expression of this antigen is also
stable in dissociated blastema cell cultures (Ferretti and Brockes, 1988).
Circumstances less dramatic than amputation are sufficient to elicit
the production of the 22/18 antigen. Local injury, such as cutting the
brachial nerve or bruising the limb, causes its expression, suggesting that
this event reflects the activation of mesenchymal cells to participate in
both repair and regeneration processes (Gordon and Brockes, 1988). These
in vivo observations extend to in vitro conditions (Ferretti and Brocl(es,
1988). The antigen 22/18 is present in cultures of normal limb, heart, and
liver tissues, but is virtually absent from such tissue sections. The
preparation of cultures like these, with its necessary disruption of tissue
integrity and enzymatic dissociation of cells is tantamount to injury, like
that produced in the in vivo situation. This is further emphasized by the
fact that although the number of 22/18 + cells is small in dense cultures, it
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increases when the cells are removed, or wounded, and replated at a lower
density (Ferretti and Brockes, 1988).
Not only does the 22/18 antibody identify injured and regenerating
tissues, it acts as a marlcer for a subpopulation of newt blastemal cells that
is persistently dependent on the nerve for proliferation (Kintner and
Broclces, 1985). When assayed two days after denervation, early (13 day -
majority of 22/18 + cells) and late (25 day - minority of 22/18 + cells)
newt forelimb blastemas displayed a seven-fold decrease in the tritiated
thymidine labelling index of 22/18 + cells. The 22/18 - populations was
similarly affected, but to a lesser extent, particularly in the late blastema.
Any potential candidate for the nerve-released trophic factor must
stimulate division of 22/18 + blastema cells since their proliferation is
nerve-dependent (Brockes, 1984; 1987a). Just as the initial complement of
blastema cells forms even in the absence of the nerve and does not
undergo mitosis, the expression of the 22/18 antigen does not require the
presence of the nerve or that cell division occur (Kintner and Brockes,
1985; Gordon and Brockes, 1988). This is consistent with 22/18 expression
in the absence of the nerve in vitro (Ferretti and Brockes, 1988). However,
the nerve and its trophic factor are required for blastema cell
proliferation and specifically those blastema cells which are 22/18 + Thus,
the signals governing the induction of 22/18 expression differ from the
mitogenic signals leading to 22/18 cell division. A potential role for
Schwann cells and a factor which these cells may elaborate has been
suggested in the induction of 22/18 expression (Fekete et al., 1987; Gordon
and Brockes, 1988). The presence of at least two blastema cell populations,
one that is 22/18 + and another that is 22/18 -, which are differentially
affected by denervation suggests that two systems of growth control may
also exist: one is absolutely dependent on the nerve, while the second is
not (Brockes, 1987a).
This second system of control is also intimated in studies of 22/18
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expression in the limb bud of the newt embryo (Fekete and Brockes,
1987a). The antigen is not apparent in the flank mesenchyme before
outgrowth of the bud, and is seen in less than 1% of mesenchymal cells
once the limb bud develops. Thus, although various similarities between
the initial development of a limb in the embryo and regeneration of an
amputated limb in the adult exist, the 22/18 antibody specifically marks
cells involved in regeneration and not early development. This changes
once the developing limb becomes innervated, once again showing that the
22/18 antigen is a marker for cells whose proliferation is nerve
dependent. The experimental evidence for this comes from research
examining the 22/18 reactivity in the amputated limb bud at a variety of
developmental stages (Fekete and Brockes, 1987a). Regardless of the stage
at which amputation occurs, the bud or developing limb regenerates.
When amputation takes place early, before nerves have reached the
amputation plane, no significant accumulation of 22/18 expression is
observed. In contrast, 22/18 + cells are seen to populate the blastema
when amputation is performed after the two-digit stage and nerve arrival.
These observations are not a function of embryonic development, but of
the stage of limb development. This is illustrated by the fact that at a
certain stage, the amputated forelimb will yield a 22/18 + blastema, while
the amputated hindlimb, whose development is retarded when compared
to that of the forelimb, will produce a 22/18 - blastema. Moreover, the
22/18 expressing cells are seen in close proximity to the nerve. Evidently,
the change, during regeneration of the developing limb bud, from a
22/18 - to a 22/18 + blastema is correlated with the appearance ofaxons
and Schwann cells at the amputation plane (Brockes, 1987a; Fekete and
Brockes, 1987b). As was suggested in the case of regeneration, it seems
possible that a second system of growth control, other than that provided
by the nerve, is acting on the 22/18 - negative cell population in the
normal developing limb bud. In some way, the process of innervation has
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the consequence of negating the effectiveness of this system, leaving the
blastema cells dependent on the nerve (Brockes, 1987a; Ferretti and
Brockes, 1991). This may take place by altering the responsiveness of cells
already present in the limb prior to innervation, by introducing a new
migratory nerve-dependent population of cells, such as Schwann cells, or
by employing a combination of these two scenarios (Fekete and Brockes,
198 7b).
D. The aneurogenic limb
A challenge to the theory that the nerve produces and releases a
factor which promotes blastema cell proliferation and permits regeneration
(Singer, 1952) has come from studies examining the phenomenon of
regeneration of the aneurogenic limb. Yntema (1959a; b) first described
the procedure that led to the formation of aneurogenic urodele forelimbs.
When they have reached the head process stage, prior to forelimb
emergence, two Am by s tom a embryos are fused in parabiosis with the
result that the two share a common yolk supply and, in time, a common
circulation. One of the partners undergoes surgery to remove the
ectodermal placodes and much of the neural tube; the unoperated partner
sustains the development of the other. The forelimb bud of the operated
embryo proceeds to develop normally in the absence of a nerve supply
and at the same rate as that of the other member of the pair; without the
trophic support of the nerve, however, the muscle later begins to
degenerate (Tweedle et al., 1974).
The remarkable thing about the aneurogenic limb is that, upon
amputation, it forms a blastema whose cells proliferate and form a
regenerate despite the absence of nerves (Yntema, 1959a). This line of
investigation was furthered by Thornton and Thornton (1970) who
transplanted the aneurogenic limbs to normal larvae which had had their
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forelimbs removed. After approximately ten days, the brachial nerves of
the host have innervated the transplant. If the limb is denervated at this
point and then amputated, the limb will regenerate as usual. However,
between days 10-13 after transplantation this changes and regeneration
becomes nerve dependent. Furthermore, they found that transplanted
limbs that were left for 33 days and then kept denervated for another 30
days regained their ability to regenerate in the absence of nerves in 50% of
the animals tested. This situation is contradictory to that seen for the
normal limb, which, even if maintained in a denervated state for 7-8
weeks does not lose its nerve-dependence upon amputation and thus does
not regenerate (Liversage and McLaughlin, 1983; Scadding, 1984).
The different circumstances under which the normal and
aneurogenic limbs regenerate extends to a detectable difference at the
molecular level. Therefore, unlike the normally innervated limb, the
aneurogenic limb regenerates with a 22/18 - blastema; it is predicted that
once the limb is innervated and under the control of nerve dependent
regeneration, it would regenerate with a 22/18 + blastema (Fekete and
Brockes, 1988; Ferretti and Brockes, 1991).
The situation seen for the aneurogenic limb resembles that seen for
the preinnervated limb bud and, once again, a second system of growth
control, other than that provided by the nerve, is suggested. Evidently, a
change from nerve-independent to nerve-dependent growth control has
taken place in both of these cases and the 22/18 antibody serves as a
marker for this transition; a nerve-independent system of growth control
also seems to be functioning in the 22/18 - cells of the normally
innervated blastema, particularly at later stages of regeneration (Fekete
and Brockes, 1987b). Although the 22/18 antibody detects a change in the
cells at the time of amputation in the presence of nerves, it is not known
whether this effect is a consequence of an earlier one that occurred upon
innervation (Fekete and Brockes, 1988). Attempts to explain how nerves
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control regeneration have led to the proposal of at least two hypotheses
(Singer, 1978; Wallace, 1981; Brockes, 1987a). One possibility is that the
non-neural cells of the developing limb produce other growth factors that
stimulate blastema cells of the regenerate to divide, but the presence of a
nerve supply suppresses this production and causes proliferation to
become nerve-dependent. Singer (1978) has suggested that the same
trophic activity exhibited by the neuron is common to all cells, but that the
great excess of this agent made in the nerve spills over to the surrounding
cells, thereby diminishing their production of the factor. Another
alternative is that nerves or their trophic material alter the limb cells in
such a manner that they are no longer responsive to growth factors other
than those manufactured by the nerve (Brockes, 1987a). Either scenario
has the limb becoming "addictedtf to the nerve as its source of the mitogen
(Brockes, 1984). The results of experiments employing the 22/18
antibody support the latter hypothesis (Fekete and Brockes, 1987b; 1988).
Brockes and his colleagues propose a role not only for nerve axons in
the establishment of nerve-dependent limb regeneration, but also for
blastema cell precursors arising at the amputation site and particularly for
Schwann cells (Brockes, 1984; 1987a; Fekete and Brockes, 1987b; 1988).
When innervation takes place, it is not merely axons which invade limb
tissue, but also their associated Schwann cells. Upon amputation of the
normally innervated limb, axons transiently retract from the amputation
plane, leaving behind a small segment of denervated Schwann cells. It
appears then that the common thread tieing all cases of a 22/18 + nerve-
dependent blastema together is amputation in the presence of denervated
Schwann cells (Brockes, 1987a). This contention is supported by a number
of observations. For example, regeneration is inhibited in irradiated limb
stumps even though axonal growth continues unhindered (Wallace and
Wallace, 1973); loss of regenerative capacity may be a result of the
suppression of Schwann cell division (Maden, 1977). Moreover, Schwann
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cells have been shown to contribute to the cells of the blastema and
express the 22/18 antigen in response to injury and amputation (Kintner
and Brockes, 1984; 1985; Gordon and Brockes, 1988). The presence of
22/18 + Schwann and interstitial cells upon amputation of the denervated
limb adds further credibility to the notion that it is denervated Schwann
cells at the amputation plane, and not axons alone, that give rise to a
22/18 + nerve-dependent blastema (Kintner and Brockes, 1985). On the
other hand, Schwann cells are obviously unable to contribute to cells
forming the blastema of a regenerating preinnervated limb bud or
aneurogenic limb and so a 22/18 - nerve-independent blastema results
(Brockes, 1984; 1987a). Furthermore, the demonstrated growth factor
requirements of Schwann cells in vitro can be supplied by the mitogen
glial growth factor, an activity residing in the innervated, but not
denervated newt blastema (Brockes and Kintner, 1986). By early removal
of the neural crest, researchers hope to acquIre newt limbs containing
axons, but lacking Schwann cells; they anticipate that amputation of such
limbs will give 22/18 - blastemas (Brockes, 1987a; Fekete and Brockes,
1988).
E. The nature of the nerve's trophic factor
Ever since Singer (1943) first proposed his trophic theory in which
nerves elaborate a factor which promotes blastema cell proliferation and
thereby permits regeneration to take place, numerous researchers have
sought to identify the molecule responsible (Singer, 1978; Wallace, 1981;
Brockes, 1984; Brockes and Kintner, 1986; Liversage, 1987). The
causative agent is sometimes referred to as the neurotrophic factor,
however this term is confusing since it has disparate meanings. In the
present context, the molecule being discussed has the characteristics of a
mitogenic growth factor. The term neurotrophic factor is used to describe
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the substances released by nerve targets to ensure the survival of those
developing neurons which are able to secure the molecule on their
receptors (Barde, 1989); this label is also given to the factors involved in
the various effects nerves have on muscle which are independent of cell
division (Brockes, 1984).
Although the nature of the nerve's growth stimulus is unknown, it is
unlikely that electrical impulses are involved (Wallace, 1981). This
conclusion is based upon the fact that both sensory and motor neurons can
promote regeneration even though their axons typically propagate
impulses in opposite directions. This, in turn, sug,gests that repeated
activation or use of a nerve's target tissue is not necessary to mediate the
trophic response, an assumption supported by the observation that normal
regeneration can occur even under conditions of prolonged paralysis
induced by botulinum toxin (Drachman and Singer1 1971).
Various pieces of evidence point to a soluble, diffusible factor as
being the nerve's trophic agent in limb regeneration (Singer, 1978;
Brockes, 1984; Carlone and Mescher, 1985). Perhaps the first indication of
the chemical nature of this factor came from the studies of Lebowitz and
Singer (1970) in which they observed that the infusion of aqueous extracts
of spinal ganglia into denervated blastemas in vivo caused an increase in
the rate of protein synthesis to control levels. This effect could be
mimicked by injection of aqueous extracts of central nervous tissue and
could be prevented by inactivation of the factor by heat or trypsin
treatment (Singer et al., 1976); these findings more specifically implicate a
soluble protein in the role as the nerve's factor. Moreover, when the
regenerate is physically isolated in culture from sensory ganglionic
neurons by a filter of very low porosity (0.45 Jlffi or 0.05 Jlm) (Globus and
Vethamany-Globus, 1977; Tomlinson et al., 1981), the blastema cells
divide. Since cytoplasmic processes from both the nerves and the
regenerate are too large to penetrate the filter, only a chemical released by
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the nerve is small enough to pass through it. The factor must also be
diffusible since the highest mitotic index is observed in those blastema
cells located closest to the nervous tissue (Globus and Vethamany-Globus,
1977). In addition to demonstrating the chemical nature of the nerve's
trophic molecule, these experiments bring to light another important
feature of this system: direct physical contact between neuronal processes
and blastemal cells is not required for the induction of a mitogenic effect
(Globus and Vethamany-Globus, 1985). This is evidently the case despite
early suggestions to the contrary (Salpeter, 1965; Tassava and Olsen,
1985).
Evidence for the supposition that the trophic factor is produced in
the neuronal cell body and delivered to the target cells via the axonal
ending (Singer, 1978) is provided by studies showing 3H-Ieucine-Iabelled
protein transport during axonal regeneration in larval and adult limbs
(Scadding and Liversage, 1979; Lentz, 1972). Wallace (1981) compiled
data from various laboratories to conclude that in order for RNA synthesis
in the ,blastema to decline within six to twelve hours following
denervation, the trophic factor must be depleted in a manner consistent
with fast axonal transport (Singer and Caston, 1972).
Researchers attempting to determine the chemical agent responsible
for the nerve's mitogenic influence on the regeneration blastema have
employed both in vivo and in vitro methods of testing (Wallace, 1981;
Globus and Vethamany-Globus, 1985; Carlone and Mescher, 1985). Initial
strategies involved an attempt to replace the trophic factor missing from
amputated denervated limbs by injecting or infusing various substances or
extracts in vivo, thereby hoping to stimulate complete regeneration.
Although a limited amount of growth was observed in some cases (Kamrin
and Singer, 1959), these types of experiments have not been fruitful.
Other studies which anticipated excessive regeneration or its inhibition
upon the injection of test solutions were also, for the most part,
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unsuccessful (Wallace, 1981). The downfall of this type of assay is the
difficulty in mimicking the postulated prolonged delivery of the trophic
factor under laboratory conditions (Singer, 1978). For this reason, a more
successful technique has been to measure the effects of test chemicals and
extracts on the rates of macromolecular synthesis and mitosis, systems
operating on a much shorter time scale than full regeneration. This
method was used by Lebowitz and Singer (1970) in studies demonstrating
the ability of nervous tissue extracts to overcome the decline in protein
synthesis following denervation of the amputated newt limb. Goldhamer
et al (1992) have suggested that maintaining cell cycle activity in short-
term in vivo experiments with trophic factor candidates may be a more
realistic and productive strategy than restimulation bioassays.
Furthermore, researchers have applied their ability to maintain explanted
amphibian blastemas in organ culture to the development of in vitro
bioassays that test the effectiveness of known chemicals and extracts on
protein and DNA synthesis as well as mitosis (Globus and Vethamany-
Globus, 1977; 1985; Choo et al., 1978; Carlone and Foret, 1979). The in
vi t ro system is advantageous since it is convenient, allows the blastema to
be isolated from factors delivered by way of the circulatory system, solves
the problem of regrowth of nerve fibers into denervated regenerates in
v i v0, and permits experimental flexibility. Even though some may argue
the validity of extrapolating in vitro results to in vivo circumstances,
studies have shown that qualitatively and quantitatively similar changes
in the rate of macromolecular synthesis occur in both cases (Choo et al.,
1978; Mescher and Loh, 1981; Singer, 1974). Preliminary investigations of
candidates for the nerve's trophic factor are often undertaken by testing
their mitogenic effect on cultured cells, particularly cell lines such as
murine 3T3 fibroblasts (Brockes, 1984). Maier and Miller (1992) recently
demonstrated that dissociated cultures of newt limb blastema cells were
also suitable for testing blastema cell proliferation in response to a crude
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newt brain extract.
When testing a trophic factor for its potential role in nerve
dependent limb regeneration, Brockes (1984) has outlined four criteria
which it must meet: 1) the factor must be present in the blastema, 2) its
level must decrease following denervation of the blastema, 3) it must
stimulate cell division of the blastema cell population which is dependent
on the nerve for proliferation (namely, 22/18 + cells of the blastema), and
4) an antibody against the factor should block its biological activity and
prevent the mitogenic effects of the nerve, thereby mimicking
denervation. While no single molecule has yet satisfied all four
requirements, a growing list of substances are potential candidates and
have already met some of these criteria.
The discovery that nerve impulses are mediated by the secretion and
transport of chemicals known as neurotransmitters at the neuronal
synapse led researchers to investigate the possibility that these molecules
might have a dual role, functioning also as the nerve's trophic factor which
participates in limb regeneration (Singer, 1978; Carlone and Mescher,
1985). Various experiments have conclusively eliminated acetylcholine as
a candidate. In the aforementioned investigation by Drachman and Singer
(1971), botulinum toxin produced its paralyzing effects by blocking the
release of acetylcholine from nerve endings and yet regeneration
proceeded unhindered. This is supported by in vivo and in vitro studies in
which acetylcholine was administered to denervated urodele limbs or
cultured limb regenerates, but was found to elicit no mitogenic response
(Singer, 1960; Foret and Babich, 1973); in fact, this neurotransmitter
reduced protein synthesis in cultured blastemas (Foret and Babich, 1973).
Furthermore, it is also unlikely that norepinephrine is the elusive factor
since regeneration normally takes place in the absence of sympathetic
neurons which release this neurotransmitter (Singer, 1943). Like
acetylcholine, norepinephrine is an ineffective proliferative agent for both
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denervated and cultured blastemas (Rathbone et al., 1980).
The results of experiments conducted using the neuropeptide
substance P are more ambiguous. Globus et ale (1983) demonstrated that
this undecapeptide was mitogenic for cultured blastemas at picomolar
concentrations. Further evidence for a possible role as the nerve trophic
factor involved in blastema cell proliferation in vivo can be seen in
continued studies which illustrated that antiserum to substance P caused a
suppression of the mitotic index of blastemas cocultured with dorsal root
ganglia; this negative effect on cell division decreased with progressively
lower antibody concentration (Globus et ai., 1983). This research group
has also found that immunofluorescent substance P is consistently localized
in the periphery of epidermal cells of the newt limb blastema (Globus and
Vethamany-Globus, 1985) and that this immunofluorescence gradually
diminishes following denervation of the limb (Globus et al., 1991).
Moreover, the discovery that substance P is present at high concentration
in the synaptosomal fraction of subcellular fractions of rat hypothalmic
tissue (Whittaker et ai., 1964) coincides with the finding that the desired
trophic factor resides within synaptosomes (Singer et al., 1976). It has
been suggested that one mechanism whereby substance P may mediate its
effect on the blastema cell proliferation is by stimulating the inositol
phospholipid signaling pathway (Globus et al., 1991). However, while this
neurotransmitter has been found to be abundant in the hypothalamus,
sensory neurons, and sympathetic nerve fibres (Jessel, 1981), it has not
been detected in motor neurons. A role for substance P as the sought-after
blastema mitogen is suspect in light of the fact that motor neurons alone
can promote regeneration, even though they are less effective than a
sensory nerve supply (Singer, 1952). While most neurotransmitters have
been eliminated as candidates, the arguments supporting a role for
substance P in blastema cell proliferation during limb regeneration are not
entirely convincing either. Thus, the identity of the nerve's trophic agent
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remains to be elucidated. Singer (1978) proposed that not merely one
factor exists, but several of these chemicals contribute to an ongoing
molecular "conversation", with target cells selecting the molecular "words"
which they recognize. Such a scheme allows for the presence of and
encourages the quest for numerous relevant blastema mitogens.
The experiments of Lebowitz and Singer (1970) were a pioneering
attempt to isolate the trophic factor by making a crude extract from newt
brachial nerves. As previously mentioned, the extract promoted an
increase in protein synthesis when infused into denervated blastema i n
v i vo. Singer and his colleagues subsequently found the activity was also
present in homogenates of central nervous tissue which were also found to
increase DNA synthesis in denervated regenerates (Singer, 1974; Singer e t
al., 1976). Other researchers have noted that spinal chord extracts from
axolotls with regenerating late bud stage limbs are more potent than such
extracts from control unamputated animals, causing an increase in the
mitotic index of cultured blastema cells (Boilly and Albert, 1988).
The mitogenic activity was reasoned to be a protein based on the fact
that it was heat labile and trypsin sensitive. Moreover, the active
component remained stable when frozen for at least two months, was
thought to be basic, and was estimated to have a molecular weight of less
than 300,000 Da. Because synaptosomes derived from frog brain also
appeared to possess the trophic factor, this mitogen lacks species
specificity (Singer et al., 1976).
This line of investigation was furthered by Choo et ale (1978) who
determined that aqueous extracts from the brains of both adult newts and
chick embryos could prevent the alterations in protein synthesis (initial
rapid increase followed by a decrease) observed in cultured blastemas.
The presence of similar trophic activities in both the newt and chick brains
parallels the finding of Singer and his colleagues that the factor lacks
species specificity (Choo et al., 1978; Singer et al., 1976). Furthermore, the
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chick-derived mitogen was also heat labile, protease and trypsin sensitive,
but ribonuclease insensitive, confirming Singer's earlier suggestion that the
factor is a peptide or protein. Continued purification of the chick brain
factor indicated that the crude extract was composed of basic proteins
which could be resolved into slow and fast running components based on
their electrophoretic behavior on a polyacrylamide gel; each of these
regions was further separated into five common proteins having molecular
weights ranging from 13,500 to 47,000 Da (Choo et al., 1981). In contrast
to the isolation made by Singer et ala (1976), the activity found in the chick
brain supernatants is unstable to freezing.
A number of more well-characterized growth factors derived from
neural tissues have been implicated as candidates for the regenerating
urodele limb's nerve-released trophic agent. In particular, researchers,
like Choo et ale (1978), have found it advantageous to examine the
relevance of neural growth factors from higher vertebrates in limb
regeneration since the small size of the amphibian nervous system has
proved unsuitable for the extensive purification of a blastema mitogen.
For example, a mitogen from chick embryo brains that differs from those
reported by Choo et ala (1981) has also been partially characterized.
Termed chick-brain-derived growth factor (CBGF), it stimulates DNA
synthesis in cultured newt limb regeneration blastemas. It was originally
characterized as a trypsin sensitive basic peptide of low molecular weight
(approximately 1500 Da) that has also been isolated from adult chick and
newt brains (Carlone and Rathbone, 1985; Carlone et al., 1987). This
molecule is stable to heating, freezing, and treatment with RNase, DNase
(Carlone, unpublished results), and the disulfide bond reducing agent B-
mercaptoethanol (Carlone and Rathbone, 1985). What distinguishes this
trophic agent from those of Singer et ale (1976) and Choo et ale (1981) are
its small size and heat stability. Moreover, CBGF appears to be chemically
distinct from other low molecular weight blastema mitogens such as
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substance P and epidermal growth factor (Globus et al., 1983; Mescher and
Loh, 1981). Detailed discussion of CBGF can be found in the following
section.
Hydra head activator (HHA) is a neuropeptide (1,142 Da.) originally
isolated from the freshwater coelenterate Hyd ra where it controls head-
specific growth and differentiation processes (Schaller and Bodenmiiller,
1981). Since then, HHA has been found in human and bovine brain, as
well as rat intestine (Bodenmiiller and Schaller, 1981). In addition to its
role as a morphogen in Hyd ra, this neuropeptide acts as an autocrine
growth factor for neuroblastoma cell lines (Schaller et al., 1989) and
promotes DNA, RNA, and protein synthesis in cultured chick embryo brain
cells (Kajiwara and Sato, 1986). Recently, HHA expression was
demonstrated in the the adult newt brain, eye, intestine, and regenerating
blastema. However, in the blastema, HHA was localized to the apical
epidermal layer, with only very low levels evident in the mesenchyme,
suggesting that it is synthesized in the wound epithelium (Fuentes et al.,
1993). Furthermore, only limited blastema growth was apparent in a
small number of denervated limb regenerates implanted with HHA-soaked
beads (Fuentes et al.,1993).
Transferrin, a common growth factor for cells in vitro (Barnes and
Sato, 1980) and a demonstrated myoblast mitogen (Stamatos et al., 1983)
has also been shown to exert a trophic influence on the denervated newt
forelimb blastema by increasing DNA synthesis and the mitotic index both
in vivo and in vitro (Mescher and Munaim, 1984; Carlone and Mescher,
1985; Mescher and Kiffmeyer, 1992); in fact, transferrin has been found to
be as effective as neural extract or serum in effecting blastema cell
proliferation in vitro (Mescher and Munaim, 1984; Albert and Boilly,
1988). Transferrin, the major iron transport protein in vertebrate blood,
can also be purified from central and peripheral nervous tissue (Stamatos
et al., 1983; Popiela et al., 1984). Mescher and Munaim (1984) found that
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the mitogenic effect exhibited a bell-shaped dose response and argued that
transferrin was involved in the delivery of iron to blastema cells via
specific receptors on their surface. Interestingly, the blastema growth-
promoting activity found in neural extracts can be removed by dialysis
with an iron-chelating agent and completely restored by readdition of iron,
strongly suggesting a role for transferrin during blastema cell proliferation
(Munaim and Mescher, 1986). Recently, it was demonstrated that
transferrin concentrations increase dramatically in the sciatic nerves of
adult axolotls during limb regeneration and was found to be distributed in
both axons and Schwann cells; moreover, transferrin is carried by fast
anterograde axonal transport and released from distal regenerating axons
(Kiffmeyer et al., 1991). These authors also demonstrated that axotomy
causes a reduction in the transferrin concentration of early bud stage
blastemas, but does not result in its complete depletion (Kiffmeyer et al.,
1991); this residual transferrin may be supplied by the vasculature. To
facilitate the phase of rapid proliferation required during the largely
avascular early stages of regeneration, these researchers reasoned that
nerves would supplement the supply of transferrin provided to the
blastema vascularly (Kiffmeyer et al., 1991; Mescher, 1992). This situation
mirrors Singer's proposal; under the conditions of nerve-dependent limb
regeneration, the nerves release large quantities of a trophic factor which
is already ubiquitously available to cells, but in much smaller amounts
(Singer, 1978).
Acidic and basic fibroblast growth factors (aFGF and bFGF), members
of the family of fibroblast or heparin-binding growth factors, were initially
isolated from bovine pituitary and brain as potent mitogenic agents for
3T3 fibroblasts in vitro (Oospodarowicz, 1974; 1987). Since that time,
members of the FGF family have been found to affect the proliferation and
differentiation of a wide variety of cell types of mesodermal and
neuroectodermal origin, with some of the FOFs demonstrating transforming
potential (Baird and Walicke, 1989; Burgess and Maciag, 1989); FOP has
also been implicated as having a role in blastema cell proliferation during
amphibian limb regeneration (Oospodarowicz, 1990).
Early in vivo studies demonstrated the ability of FGF to promote the
resumption of mitotic activity in mesenchymal cells when infused into
denervated newt forelimb blastemas (Mescher and Gospodarowicz, 1979).
In subsequent in vitro experiments, FGF was found to be as effective as an
optimal dose of newt brain extract in stimulating DNA synthesis (Mescher
and Loh, 1981) and mitosis (Carlone and Foret, 1979; Carlone et al., 1981).
More specifically, Albert et ale (1987) concluded that while both acidic FGF
(aFGF) and basic FGF (bFGF) behaved as mitogens for cultured blastema
cells, bFGF was more effective than aFGF.
Recently, the blastema has been found to contain neurotrophic and
mitogenic factors (Baudin et al., 1988; Boilly, 1989). Co-culture of
blastemas with spinal cord explants promoted spinal neurite outgrowth
and neuronal survival; this neurotrophic effect was specific to the
mesenchymal component and not the epidermal cap. On the other hand,
crude blastema extracts were mitogenic for cultured blastema cells, with
epidermal cap extracts being more effective than the corresponding
mesenchymal extracts (Boilly and Albert, 1990). These differing blastemal
effects are apparently mediated by different chemical agents (Boilly,
1989). However, aFGF may be one of the factors responsible for the
blastema's mitogenic effects (Boilly, 1989; Boilly et al., 1991).
Evidence suggests that an aFGF-like molecule is present in both the
epidermal cap and blastema mesenchyme (Boilly, 1989; Boilly et al., 1991).
Furthermore, heparin, a well-documented potentiator of the mitogenic
activity of aFGF, but not bFGF (Esch et al., 1985), enhances the mitotic
index of cultured blastema cells in a dose dependent fashion (Boilly, 1989).
This result is surprising in light of the fact that heparin alone has been
found to inhibit cell proliferation in a wide variety of cell types by
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affecting a critical event during the mid-G1 phase of the cell cycle (Reilly
et al., 1989). Moreover, a polyclonal antibody against bovine aFGF stained
both the epidermal cap and mesenchyme of sectioned blastemas, with
mesenchymal reactivity particularly associated with the extracellular
matrix. Boilly asserts that these findings argue for the presence of an
endogenous aFGF-like molecule in the blastema, but maintains that this
factor provides only a mitogenic and not neurotrophic activity (Boilly,
1989). Although the production site of the aFGF-like molecule is unknown,
a number of potential places of origin exist: the nerves, the epidermal cap,
and the mesenchymal cells of the blastema , with the extracellular matrix
acting to sequester the FGF (Boilly et al., 1991).
Since the extracellular matrix has been implicated in the control of
cell cycle events and because FGF has been shown to induce the synthesis
and secretion of various extracellular matrix components by cultured cells
(Gospodarowicz, 1983), Mescher and his colleagues have examined a
possible relationship between these actions. Following amputation of the
amphibian limb, extracellular components of tissues are broken down, but
production of hyaluronate, a large glycosaminoglycan which is a principal
component of embryonic mesenchyme, begins (Mescher and Munaim,
1986). Like blastema cell proliferation, synthesis of hyaluronate is nerve
dependent; in fact, it appears that these two events in regeneration are
coordinately regulated, with hyaluronate production playing an integral
part in the proliferative response of mesenchymal cells (Matlloka et al.,
1987; Mescher and Cox, 1989). Interestingly, FGF, a known blastema
mitogen in vitro, also stimulates hyaluronate synthesis in cultured
blastemas (Mescher and Munaim, 1986).
Receptor binding assays have suggested the presence of high affinity
FGF receptors in the blastema mesenchyme, with low affinity binding sites
in the epidermal cap; the epidermal cap also has a high level of heparan
sulfate (Boilly et al., 1991; Hondermarck and Boilly, 1992). Together, these
4 1
data intimate that the extracellular matrix of the epidermal cap binds and
stores FGF which is then somehow released to the target high affinity
receptors of the mesenchyme (Boilly et al., 1991), the transduction sites of
the FGF signal (Moscatelli, 1987). Other researchers have expanded this
line of investigation by isolating cDNA clones representing two different
members of the FGF receptor family from a newt limb blastema cDNA
library: FGFR1 and both the be k and KGFR (keratinocyte growth factor
receptor) variants of FGFR2 (Poulin et al., 1991; 1993). By employing in
situ hybridization, FGFR1 is found to be homogeneously expressed
throughout the blastema mesenchyme, but is absent from the wound
epithelium (Poulin et al., 1993). Conversely, during the growth and
blastema cell proliferation stages of the regenerate, FGFR2 is expressed in
the basal layer of the wound epithelium and in the mesenchyme closely
associated with the bisected bones; later, during differentiation, FGFR2
expression becomes restricted to the condensing cartilage and then the
perichondrium (Poulin et al., 1993). In other species it has been
determined that aFGF, bFGF, and FGF-4 are ligands for FGFR1, while aFGF
and either bFGF or KGF, depending on the receptor isoform, are ligands for
FGFR2 (Dionne et al., 1990; Johnson et al., 1991; Mansukhani et al.,
1990;1992; Miki et al.,1992; Yayon et al., 1992). In any case, FGF appears
to function during limb regeneration and may have a mitogenic and/or
angiogenic role (Boilly et aI., 1991).
The FGF family of growth factors also seems to play a part the
developing limb bud. FGF-l (aFGF), FGF-2 (bFGF), FGF-4, and FGF-5 each
cause embryonic mouse limb outgrowth in vitro by stimulating
proliferation of cells in distal limb mesenchyme from which the apical
ectodermal ridge (AER) has been removed; other factors such as epidermal
growth factor (EGF), platelet-derived growth factor (PDGF), and insulin
have no effect (Niswander and Martin, 1993; Niswander et al., 1993).
Moreover, fgf- 4, the gene encoding the FGF-4 protein, is expressed in the
42
mouse AER during the period when the AER normally stimulates
proliferation of underlying mesenchyme (Niswander and Martin, 1992);
bFGF has been localized to the chick limb bud AER (Savage et aI., 1993).
Recently, bFGF-loaded beads, pinned onto amputated chick wing buds,
induced regeneration of digit-like structures, suggesting that the lack of
regenerative ability in the chick is due to the inability of the amputated
limb bud to reform a competent AER (Taylor et al., 1994); this finding is
particularly important in light of the fact that it represents the first time a
chemically defined agent has successfully induced a regenerative response
in a higher vertebrate limb. In addition, fibroblast growth factor receptors
have been studied during limb bud development: FGFR1 is expressed in
the mouse limb bud mesenchyme, while FGFR2 is expressed predominantly
in epithelium (Peters et al., 1992); these findings mimic, in part, those
observed by Poulin et al. (1993) in the newt limb regenerate.
Perhaps the molecule fulfilling the most of Brockes (1984)
requirements of a mitogen involved in nerve dependent amphibian limb
regeneration is glial growth factor (GGF) (Brockes and Kintner, 1986). GGF
was initially isolated from bovine brain and pituitary based on its
mitogenicity for cultured Schwann cells (Brockes et aI., 1979; 1980). The
activity, absent from non-neuronal tissue (Raff et al., 1978), is most
abundant in human acoustic neuromas, Schwann cell tumours associated
with the auditory nerve (Brockes et aI., 1986). GGF-like activity has also
been detected in nervous system extracts of the human, rodent, chick, frog,
newt, and axolotl (Brockes, 1984; 1987b) and the newt regeneration
blastema (Brockes and Kintner, 1986).
Originally reported to be a basic 31,000 Da. protein which could form
a 56,000 Da. dimer (Lemke and Brockes, 1984), three Inajor GGF isoforms
have recently been purified: GGF-I (34,000 Da.), having properties similar
to the previously isolated GGF, GGF-II (59,000 Da.), and GGF-III (45,000
Da.) (Goodearl et al., 1993). Each of the three GGFs displays a sigmoidal
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dose-dependent stimulation of Schwann cell DNA synthesis, with a half-
maximal activity of 1 nM (Goodearl et al., 1993); previous purifications of
GGF demonstrate its mitogenicity for rat astrocytes, fibroblasts (Brockes e t
al., 1980), and enteric glial cells (Eccleston et al., 1987), but its lack of
effect on oligodendrocytes and macrophage-like microglia (Brockes et al.,
1980). Recently, GGF-II was shown to instructively promote glial
differentiation while inhibiting neuronal development of multipotent
neural crest stem cells (Shah et al., 1994). GGF mRNA is expressed in the
embryonic spinal chord and brain (Marchionni et aI., 1993).
GGF-I, -II, and -III are encoded by a single gene, which appears to
encode other GGF-related Schwann cell mitogens, and are generated by
alternatively spliced mRNAs (Marchionni et al., 1993). Moreover, other
products of this same gene include the heregulin (HRG) (Holmes et aI.,
1992) and neu differentiation factor (NDF) (Wen et al., 1992), putative
ligands of the c-Neu/erbB2/HER2 and erbB4/HER4 receptor tyrosine
kinases (Lemke, 1993; Plowman et al., 1993). The GGFs are also suggested
to be neu activators (Marchionni et al., 1993); interestingly, the neu
(erbB2) receptor is expressed on the surface of Schwann cells where it is
upregulated during Wallerian degeneration and by exposure to forskolin
(Cohen et al., 1992), an adenyl cyclase activator which also synergizes with
the GGFs (Goodearl et aI., 1993). Yet another protein encoded by this gene
is acetylcholine-receptor-inducing activity (ARIA), a trophic factor which
stimulates the synthesis of muscle acetylcholine receptors (Falls et aI.,
1993) .
The GGFs are thought to play a role in glial cell proliferation during
development and regeneration in the nervous system (Lemke and Brockes,
1984; Marchionni et al., 1993). It is in the latter context that GGF has been
implicated in the nerve-dependent proliferation of blastema cells in the
regenerating amphibian limb. This mitogen satisfies three of the four
criteria outlined by Brockes, namely: (1) GGF is present in the normally
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innervated blastema, with its level increasing approximately sevenfold
upon amputation and continuing to increase during the following four
weeks; (2) GGF levels in the blastema decrease following denervation; and
(3) both newt brain and bovine pituitary GGF increase the thymidine
labelling index of 22/18 + cells in denervated blastemas in vitro (Brockes
and Kintner, 1986). As previously mentioned, the proliferation of 22/18 +
cells in the blastema is nerve dependent (Kintner and Brockes, 1985).
While most of the research in the regeneration field has focused on
positive models of growth control by the nerve, Ferretti and Brockes
(1991) point out that a negative growth control scenario is equally
possible. Schwann cells, for example, could release a factor inhibitory to
blastema cell proliferation, with production of the factor ceasing upon the
return ofaxons to the amputation plane.
Furthermore, the means of transduction of the mitogenic signal are
still to be ascertained. For example, the proliferative response of blastema
cells to a neurally derived mitogen may be mediated by an elevated
intracellular concentration of Ca2 +, which in turn causes increased cGMP
levels and decreased cAMP levels; in contrast, the opposite condition, in
which a calcium efflux yields elevated cAMP levels and suppressed cGMP
levels is suggested to result in the depression of blastema cell divisions
(Globus et al., 1987). In fact, increased blastema cell cAMP levels result
when the newt limb is denervated and are associated with blastema
differentiation (Boilly et al., 1990; 1992). Protein kinase C (PKC) is also
implicated as a potential second messenger in the signal transduction of
the nerve's trophic factor (Oudkhir et al., 1989; Boilly et al., 1990). An
increase in mesenchymal PKC activity in conjunction with a translocation of
this PKC activity from cytosol to membrane is correlated with blastema cell
proliferation, while denervation has the opposite effect (Boilly et al., 1990;
1992); similar observations were also made for PKC activity in the eNS of
newts undergoing limb regeneration (Oudkhir et al., 1992).
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Chick Brain Growth Factor
A. Purification of CBGF
Chick brain growth factor (CBGF) was initially purified from adult
chicken brain (Carlone and Rathbone, 1985). Brains were subjected to
homogenization, followed by ultracentrifugation and pressure
ultrafiltration through a series of Amicon Diaflo membranes of decreasing
porosity (nominal molecular weight cutoffs: 30,000 Da., 2,000 Da., and
500 Da.). The biologically active material was retained on a type UM-05
membrane having a nominal molecular weight cut-off of 500 Da. This
fraction was further purified by chromatofocusing. Subsequently, CBGF
was purified from 18 day chick embryos by employing the same protocol
of homogenization, ultracentrifugation, and pressure ultrafiltration as
described for isolation of this factor from adult chick brains (Carlone et al.,
1987). This sequence of events was followed by DEAE (diethyl amino
ethyl) ion exchange chromatography of the UM-05 retentate. Finally, the
biologically active fraction isolated from the ion exchange column was
submitted to reversed-phase high performance liquid chromatography
(rp-HPLC) (using a shallow gradient of 0-10% acetonitrile in 0.05%
trifluoroacetic acid (TFA) over a 10 minute period). Most of the active
material eluted in the largest of the four UV-absorbing peaks obtained;
repeated rp-HPLC of this fraction under various elution conditions
continuously resulted in an apparently homogeneous single peak
maintaining biological activity. Using this protocol, a purification of
25,000 fold was achieved. More recently, the UM-05 retentate was
directly applied to the rpHPLC column, omitting the DEAE ion exchange
chromatography step (M. Seifried, honours thesis, 1988). The separation
produced at least nine UV-absorbing peaks with the most active fraction
eluting in a small shoulder of a much larger peak. Interestingly, this large
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peak, found by other researchers to contain an agent that stimulated chick
astrocyte proliferation (Rathbone, personal communication) was
determined to be inactive when tested on chick astrocytes in the
aforementioned honours thesis work.
This procedure, as outlined for the purification of CBGF from
embryonic and adult chick brain, has also been employed to prepare a
biologically active UM-05 retentate fraction from the adult newt brain
(Carlone and Rathbone, 1985). Thus, since a CBGF-like molecule also
appears to be present in the nervous system of the newt, CBGF is said to
lack specificity. This lack of species specificity was also characteristic of
GGF (Brockes, 1984) as well as the blastema mitogens isolated by Singer e t
ale (1976) and Choo et ale (1978).
B. Biological activity of CBGF
CBGF was initially purified in an attempt to isolate the nerve's
trophic factor involved in the control of blastema cell proliferation (Carlone
and Rathbone, 1985). Earlier work had established that the trophic
activity could be found in extracts of both newt peripheral nerves and
brain (Lebowitz and Singer, 1970; Singer et al., 1976); chick embryo
brains were discovered to contain a comparable mitogenic agent which,
when administered to cultured blastemas, prevented the alterations in
protein synthesis characteristic of denervated blastemas in vitro and i n
vivo (Choo et al., 1978). As a result, CBGF was first tested on cultured
blastema explants and was found to be a potent stimulator of DNA
synthesis with maximal activity at 10 ng/ml; the blastema tissue
displayed a bell-shaped concentration dependence for CBGF activity
(Carlone and Rathbone, 1985). The CBGF-like molecule partially purified as
a UM-05 retentate fraction from the adult newt brain was mitogenic for
newt blastema explants in vitro at a concentration of 100 ng/ml (Carlone
and Rathbone, 1985). In addition, CBGF has been determined to be
mitogenic for the mesenchyme-like cells of cultured Xenopus laevis
forelimb regenerates (Tsilfidis and Liversage, 1989). These cells also show
a bell-shaped concentration dependence for CBGF, with the factor being
most active at 1 Ilg / m1.
CBGF has also been found to increase the incorporation of
3H-thymidine into cultured Swiss mouse 3T3 fibroblasts and astrocytes
from the 10 day chick embryo brain (Carlone and Rathbone, 1985; Carlone
et al., 1988). Unlike the case for the blastema, 3T3 fibroblasts exhibit a
sigmoidal concentration dependence for CBGF activity. CBGF also
stimulated maximal division of 3T3 fibroblasts and chick embryo
astrocytes when tested at a concentration of 10 ng/ml; at this
concentration, a 3.5-4-fold increase in 3H-thymidine incorporation over
control values was realized for the chick astrocytes (Carlone et al., 1988).
CBGF was found to have no effect on the survival, proliferation, or
differentiation of other cell types from the 10 day chick embryo brain,
namely neurons and meningeal fibroblasts (Carlone et al., 1988). CBGF also
had no mitogenic effect on chick embryo skeletal muscle myoblasts,
primary mouse embryo fibroblasts and the murine teratocarcinoma-
derived STO cell line (Carlone et al., 1988).
With a half-maximal stimulation (EDso) of 3H-thymidine
incorporation into cultured chick embryo astrocytes at CBGF concentrations
of approximately 5 ng/ml (or 3 nM), CBGF activity is comparable to that of
a variety of other growth factors and neuropeptides (Carlone et al., 1987).
For example, similar values have been obtained for platelet-derived
growth factor (EDso = 1 ng/ml; Antoniades et al., 1979) acidic fibroblast
growth factor (EDso approximately 40 pg/ml; Thomas et al., 1984),
vasopressin (EDso = 1 ng/ml; Rozengurt et al., 1979), and bombesin
(EDs 0 = 1 nM; Rozengurt and Sinnett-Smith, 1983). This indicates that CBGF
acts at physiologically relevant concentrations.
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The limited array of cell types for which CBGF acts as a mitogen,
parallels, in part, the small number of cell types which respond to glial
growth factor. Like CBGF, GGF has been found to stimulate proliferation of
astrocytes (Brockes et al., 1980), fibroblasts (Brockes et al., 1981), and cells
of the regenerating newt limb blastema (Brockes and Kintner, 1986).
However, GGF has also been ascertained to be a potent mitogen for rat
Schwann cells in vitro, a cell type thought to be involved in the
proliferative events of the blastema during Urodele limb regeneration
(Raff et al., 1978; Brocl(es, 1987a). The effect of CBGF on cultured rat
Schwann cells has not been determined.
C. Biochemical characteristics of CBGF
Preliminary biochemical characteristics of CBGF have been
determined. Various pieces of evidence suggest that CBGF is a basic, low
molecular weight peptide (Carlone and Rathbone, 1985; Carlone et al.,
1987). For example, its biological activity is lost upon incubation with
either trypsin (Carlone and Rathbone, 1985) or pronase (Carlone,
unpublished results). Furthermore, CBGF activity is RNase and DNase
insensitive (Carlone, unpublished results). Preliminary attempts to
characterize the amino acid composition of CBGF, given in Table I, reveal
that the factor is a polar molecule consisting of fifteen amino acids; the
most predominant residues are glycine, glutamic acid/glutamine, and
aspartic acid/asparagine (Carlone et al., 1987). Since amino acid analysis
has consistently given the same results, the possibility that this material is
a random protein contaminant is negated (Carlone et aI., 1987). When the
HPLC separation of the UM-05 retentate is monitored at 280 nm and 205
nm, the peak height of the active fraction is higher at the lower
wavelength (M. Seifried, honours thesis, 1988). Since the only amino acids
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Table I. Am.ino Acid Com.position of CBGF
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a
Residues/11101
Amino acid Observed Nearest integer
Asx 2.4 2
Thr 0.4 0
Ser 1.2 1
Glx 3.7 4
Pro 0.2 0
Gly 4.3 4
Ala 0.7 1
Cys 0.8 1
Val 0.7 1
Met 0.1 0
lie 0.1 0
Leu 0.7 1
Tyr 0.2 0
Phe 0.3 0
Trp 0.0 0
His 0.1 0
Lys 0.4 0
Arg 0.0 0
Nle 0.0 0
Total residues 15
a
Based on an estitnated tnolecular weight of 1500 Da.
with absorbance peaks at 280 nrn are tyrosine and tryptophan, this
finding supports the amino acid analysis results which indicate the absence
of these two residues. Curiously, the nearest integer values for the amino
acid composition indicate that no lysine or arginine residues are present,
despite the fact that this mitogen is inactivated by treatment with trypsin,
an enzyme cleaving peptide bonds at the carboxy side of these two amino
acids (Pine et al., 1980).
The purification procedure for CBGF suggests that the factor has a
low molecular weight cut-off of 2,000 Da, but is retained by a membrane
having a nominal molecular weight cut-off of 500 Da (Carlone and
Rathbone, 1985). A comparison of the HPLC retention times and SDS
polyacrylamide gel electrophoresis (PAGE) mobilities (dansylated peptides)
of various standard peptides/proteins and the UM-05 retentate material
indicated that CBGF had a molecular weight of 2,000-6,000 Da (Carlone and
Rathbone, 1985). The amino acid composition of CBGF estimates the factor
to be 1,500 Da (Carlone et al., 1987), while preliminary fast atom
bombardment (FAB) mass spectrometry data approximates the molecular
weight at 1,600 Da (Carlone, unpublished data).
The relatively low molecular weight of CBGF distinguishes it from the
blastema trophic agents isolated by Singer et ale (1976; less than 300,000
Da) and Choo et ale (1981; 13,500-47,000 Da). CBGF also appears to be
smaller than some of the other well-characterized blastema mitogens such
as glial growth factor (GGF-I: 34,000 Da; GGF-II: 59,000 Da; GGF-III:
45,000 Da) (Brockes, 1984; Goodearl et al., 1993), acidic and basic
fibroblast growth factors (each approximately 18,000 Da) (Esch et al.,
1985), and transferrin (76,000-81,000 Da) (Aisen and Listowsky, 1980) as
well as other growth factors such as epidermal growth factor (6,045 Da)
(Taylor et al., 1972), and platelet-derived growth factor (30,000 Da)
(Heldin and Westermark, 1989). This may suggest that CBGF is more
closely related to neuropeptides such as substance P (1,500 Da), a
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recognized blastema mitogen (Chang et al., 1971), Hydra Head Activator
(1,142 Da) (Schaller and Bodenmiiller, 1981), and bombesin (1,620 Da)
(Woll and Rozengurt, 1989).
CBGF activity is stable to heating at 60°C, boiling, freezing at -70°C,
and treatment with the disulphide bond reducing agent (3- mercaptoethanol
(Carlone and Rathbone, 1985). The presence of only one cysteine residue,
as determined by the amino acid analysis, negates the possibility of a
disulphide linkage in CBGF (Carlone et al., 1987). Although CBGF is stored
dry and frozen at -70°C, it loses activity upon repeated freezing and
thawing (R. Carlone, personal communication).
D. Possible nucleotide content of CBGF
When a sample of CBGF was obtained from M. Rathbone and his
colleagues for further identification, it was found not to contain a peptide,
but be primarily composed of guanosine 5'-monophosphate (GMP), as
determined by IH- and 31p_ nuclear magnetic resonance (NMR)
spectroscopy (M. Seifried, honours thesis, 1988). This sample had no
biological activity when tested using the astrocyte biosassay.
Preliminary IH-NMR analysis indicated the presence of a
nucleoside/nucleotide component in those rpHPLC fractions found to be
most ineffective in the astrocyte bioassay; such components appeared to
be absent from mitogenic fractions (M. Seifried, honours thesis, 1988).
Rathbone and his colleagues later concluded that the most mitogenic
of the components which they isolated from the 18-day chick embryo
brain and purified by rpHPLC was GMP with a molecular weight of 363 Da.
(Kim et al., 1991); this conclusion was based upon a comparison of rpHPLC
retention times with ultraviolet absorption spectra, thin layer
chromatography plates, IH- and 31p-NMR spectra, and FAB mass spectra
for both the chick brain-isolated fraction and commercial GMP. They also
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found that both the chick brain-isolated material and commercial GMP
were mitogenic for 10-day chick embryo astrocytes in vitro; both
substances stimulated 3H-thymidine incorporation into these cells in a
dose-dependent fashion, with maximal activity at 50 llffi (Kim et al., 1991).
Similarly, these researchers have isolated adenosine
5'-monophosphate (AMP; 347 Da.) from the 18 day chick embryo brain
and verified its identity with commercial AMP using the same methods
employed in their GMP study; AMP was also found to be a mitogen for
10 day chick embryo brain astrocytes, stimulating maximum 3H-thymidine
incorporation into these cells at 500 nM (Rathbone et al., 1992a).
Moreover, these researchers found that guanosine, guanosine
diphosphate (GDP) , guanosine triphosphate (GTP) (Kim et ai., 1991),
adenine, adenosine, adenosine diphosphate (ADP), adenosine triphosphate
(ATP) (Rathbone et aI., 1992a), deoxyguanosine, dGMP, dGDP~ and dGTP,
deoxyadenosine, dAMP, dADP, and dATP, as well as some adenosine
metabolites such as inosine, hypoxanthine, xanthosine 5'-monophosphate
(XMP), XDP, and XTP (Christjanson et al., 1993) were also mitogenic for the
astrocytes; while these purines were found to be astrocyte mitogens,
pyrimidine nucleosides, nucleotides (with the possible exception of uridine
diphosphate), and deoxynucleotides were inactive (Christjanson et al.,
1993). Guanosine, adenosine, and their nucleotides also stimulate
proliferation of 10 day chick embryo brain meningeal fibroblasts, human
brain capillary endothelial cells, Swiss mouse 3T3 fibroblasts, and the
human astrocytoma cell lines SKMG-1 and U373, in addition to the 10 day
chick embryo brain astrocytes (Rathbone et al., 1992c); as previously
stated, CBGF has no effect on these meningeal fibroblasts, indicating that
this factor is not GMP or AMP (Carlone et al., 1988). Generally, guanosine
and its analogues were more active in stimulating cell proliferation than
the adenosine-based compounds (Rathbone et al., 1991; 1992c).
The use of various purinergic receptor antagonists has suggested that
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adenosine and guanosine mediate their mitogenic effect via activation of
an adenosine A2 receptor, while their nucleotides employ purinergic P2 y
receptors (Rathbone et aI., 1992a,c); these results further imply that
guanosine, adenosine, and their nucleotides are not merely behaving as
nutritional supplements. Since guanosine is not known to bind to
purinergic receptors, these authors surmise that it works indirectly by
inhibiting the action of adenosine deaminase on extracellular adenosine
(Rathbone et al., 1992c,e); adenosine is readily released from hypoxic,
damaged, or dying cells (Stone et al., 1990; Rathbone et al., 1992d).
Using a different purification method than that employed to isolate
GMP and AMP from the 18 day chick embryo brain, Rathbone and his
colleagues (1992b) separated eight partially purified fractions mitogenic
for cultured chick astrocytes: 24, 17, 12, 9, 5, 2.8, 1.4, and 1.2 kD. One of
the lower molecular weight fractions may represent CBGF.
The candidates for the nerve-elaborated blastema mitogen involved
in newt limb regeneration which have been discussed include substance P
(Globus et al., 1991), hydra head activator (Fuentes et al., 1993),
transferrin (Mescher and Kiffmeyer, 1992), acidic and basic fibroblast
growth factors (Boilly et al., 1991; Albert et al., 1987), glial growth factor
(Brockes and Kintner, 1986), and chick brain growth factor (Carlone et aI.,
1987). Of these, the best possibilities for such a trophic factor are
represented by transferrin, aFGF, bFGF, GGF, and CBGF. However, although
transferrin, aFGF, and bFGF are well-characterized molecules available in
sufficient quantities, little research using these factors has been directed
specifically at addressing the questions posed by Brockes (1984) in his
four criteria required of a blastema mitogen. The originally isolated GGF
was found to meet three of these requirements, but the three GGF isoforms
(GGF-I, GGF-II, and GGF-III) (Goodearl et al., 1993) subsequently purified
have yet to be tested. In an effort to eliminate or substantiate claims to a
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role in the nerve-dependent blastema cell proliferation phase of limb
regeneration, experiments aimed at testing whether these factors meet
Brockes' four criteria would be extremely valuable. In addition, once
mitogens such as CBGF are more abundantly available and more fully
characterized, experiments of this nature may also be carried out in an
effort to determine this factor's potential part in Urodele limb
regeneration.
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METHODS AND MATERIALS
Purification of Chick Brain Growth Factor (CBGF)
A. Initial isolation and ultrafiltration
The purification protocol of CBGF has been previously described
(Carlone et al., 1987); the following procedure represents an improvement
of that method.
Ten or twenty dozen live eighteen-day chick embryos were
decapitated and the brains were removed and homogenized 1: 1 (w:v) in
cold 0.02 M potassium phosphate buffer (pH 7.3) using a 50 ml glass
homogenizer. The homogenate was then centrifuged at 12,500 g for 20
minutes at 4°C. The supernatant was filtered through glass wool and then
ultracentrifuged at 105,000 g for 1.5 hours at 4°C. Supernatants were
again filtered through glass wool and then passed through a series of
Amicon Diaflo membranes of decreasing porosity. This ultrafiltration was
accomplished at 4°C using a pressure of approximately 35-40 psi. The
filtrate from the first membrane, PM-30 (nominal molecular weight cut-off
of 30,000 Da.) was applied to the second membrane, YM-2 (nominal
molecular weight cut-off of 2,000 Da.). The YM-2 filtrate was lyophilized
and stored at -70°C prior to further purification of the active component.
B. Size exclusion chromatography
The YM-2 filtrate was further fractionated by eluting it from a size
exclusion column. Biogel P6 (nominal molecular weight cut-off of
6,000 Da.) column packing was equilibrated against 0.05 M ammonium
acetate. This was used to prepare a 36x1.1 cm column with an
approximately 35 ml bed volume. The dry YM-2 filtrate was reconstituted
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in approximately 1.5 rol of the ammonium acetate buffer and filtered
through a 0.2 11M filter. The sample was eluted at a flow rate of
approximately 0.165 ml/min with 10 minute fractions being collected. The
ultraviolet (UV) absorbance of the fractions was monitored at 260 nm and
280 nrn and the peaks were pooled, lyophilized, and stored at -700C
c. Anion exchange high performance
liquid chromatography (HPLC)
Anion exchange chromatography was achieved using a Waters anion
exchange column. The active fraction, P6-3, from the Biogel P6 column
was reconstituted in distilled H20 and fractionated with the following
gradient: 0.1 % 0.007 M KH2P04 and 0.007 M KCI (pH 4.0) to 99.9% 0.25 M
KH2P04 and 0.50 M KCI (pH 5.0) in 20 minutes. The solvents were filtered
and degassed. A flow rate of 1.5 ml/min and a chart speed of 0.5 em/min
were employed. The elution profile was monitored primarily at 256 nm,
but also at 280 nm and 229 nm. Fractions were collected manually,
pooled, lyophilized, and stored at -70°C. Following the anion exchange
HPLC elutions performed on any given day, the system was thoroughly
flushed with distilled H20 in order to remove all buffer salts and prevent
corrosion of the HPLC hardware. The column was stored in CH3CN.
D. Reverse phase high performance
liquid chromatography (rp-HPLC)
Reverse phase HPLC was used to further purify the mitogen from the
P6-3 fraction of the Biogel P6 column elution. The sample was dissolved in
distilled H20 and a Waters 11 Bondapal( CI8 column was used in the
separation. Fractionation was accomplished with a fairly steep gradient of
0.1 % to 99.9% acetonitrile (CH3CN) in a doubly glass distilled H20 with
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0.05% trifluoroacetic acid (TFA) in 20 minutes; a separation was also
achieved with an initial 2 minute period in which distilled H20 with 0.05%
TFA was run isocratically prior to the onset of the gradient. The solvents
were filtered and degassed. A flow rate of 1.5 ml/min and a chart speed
of 0.5 em/min were used. Pure CH3CN was employed to purge and store
the column. To prevent precipitation of the TFA, the column was purged
with a 50:50 mixture of CH3CN:H20 and then distilled H20 alone before the
initial elution on any given day; after the final elution of the day, this
regime was followed in reverse and the column was stored in CH3CN. The
elution profile was monitored primarily at 280 nm, but also at 256 nrn.
Peaks were collected manually, pooled, lyophilized, and stored at -70°C.
Both guanosine 5'-monophosphate (5'-GMP) and adenosine
5'-monophosphate (5 f -AMP) were eluted under the conditions employed
for the fractionation of fraction P6-3.
Cell Culture
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A. Isolation of non-neuronal cells primary cultures
The non-neuronal cells used in the bioassays to determine the
biological activity of CBGF were isolated by the method of Hanson et al.
(1982). Approximately six 10 day chick embryos were decapitated and
the cerebral hemispheres were dissected into Ca2+ and Mg2 + free
phosphate buffered saline (PBS). The meninges were removed and
discarded. After mincing, the tissue was trypsinized with 5 ml 0.25%
trypsin (which had been diluted with PBS from a lOX stock solution) for
30 minutes at 37°C. The trypsin was then neutralized with 5 ml 10% fetal
bovine serum (FBS) in complete alpha-minimal ·essential medium (a-MEM)
from GIBCO (described later). The suspension was centrifuged at
1000 rpm for 5 minutes, the supernatant was removed, and the pellet was
resuspended in fresh medium. The tissue was further dissociated by
trituration (1 OX) with a Pasteur pipette followed by mechanical sieving
through a 63 11m Nitex mesh. The cell suspension was equally divided
among four to six 60 mm collagen-coated Falcon culture dishes with each
dish containing a total of 5 ml of complete medium with 10% FBS. Cells
were incubated at 37°C and 2% to 5% CO2. The non-neuronal cells were
selected by differential adhesion to the collagen-coated culture dishes.
This was accomplished by agitation of the plates for approximately
2 minutes at 30 minute intervals for 4 hours. At this time, the non-
neuronal cells were affixed to the collagen substrate and the neuronal cells
had formed aggregates in the medium. The medium was gently aspirated,
the attached cells were washed with PBS, and 5 ml fresh complete medium
with 10% FBS was added. Any remaining neuronal cells were lost upon
subsequent subculturing. The non-neuronal cells were maintained in
a-MEM supplemented with 33.3 mM D-glucose, Ix antibiotic/antimycotic
(GIBCO), 5 Ilg/ml insulin, 5 Ilg/ml human transferrin, 2x 10-8 M
progesterone, 100 mM putrescine, 3x 10-8 M sodium selenate (complete
medium) and 10% FBS. The non-neuronal cells isolated and prepared in
this way were referred to as primary cultures.
B. Collagen-coating of culture dishes
A 0.5 mg/ml collagen solution was prepared by dissolving bovine
achilles tendon collagen (GIBCO) in a 1:1000 mixture of glacial acetic
acid:distilled H20. After stirring for 24 hours, the solution was centrifuged
at 1000 rpm for 5 minutes and the pellet was discarded. Culture dishes
were coated with a small amount of collagen for one hour at which time
the excess collagen was removed and the plates were allowed to dry.
Before cells were plated onto the dishes, the dishes were washed with PBS.
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c. Subculturing of non-neuronal cells
When the primary cultures of non-neuronal cells had reached
confluence, usually after two to four days, the cells were passaged. The
medium was removed from the primary culture dishes, they were washed
with PBS, and trypsinized with 1 ml 0.25% trypsin for 8 minutes at 37°C.
The trypsin was prepared as previously described. At . this point, 5 ml
complete medium with 10% FBS was added to the dishes to neutralize the
trypsin. By trituration, the cells were lifted from the plates and the
resulting cell suspension was centrifuged at 1000 rpm for 5 minutes. The
supernatant was discarded and the pellet was resuspended in complete
medium containing 10% FBS by trituration (lOX) with a Pasteur pipette.
Large pieces of the cell sheet that were resistant to trituration were
permitted to settle by gravity. The supernatant was divided equally
among 60 mm Falcon culture dishes. The cells were incubated at 37°C and
2% to 5% CO2. Cells were confluent after approximately two to three days
at which time they were subcultured again.
Growth Factor Bioassay
A . General bioassay
Non-neuronal cells used for CBGF and nucleotide bioassays were
passaged and seeded into collagen-coated 24 well plates (Falcon) at a
density of 3x 1()4 cells/well. Experiments determining the optimum
bioassay conditions employed cells seeded at a density of
1.2 xl 05 cells/well into collagen-coated 35 mm Falcon culture dishes.
Immunohistochemical studies to determine the number of GFAP+ cells in
the culture employed cells seeded at a density of 1.2x lOS cells/dish into
35 mm culture dishes containing collagen-coated coverslips. Cells were
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grown to confluence in the centre of the wells using complete medium with
10% FBS. At this time, the cells were rendered "quiescent" with complete
medium containing either 0.1 % or 1% FBS. After the 24 hour "quiescence"
period, compete medium with 0.1 % or 1% FBS containing varying
concentrations of the test factor replaced the medium in the wells. Several
replicates of each concentration were used in the assay. The
concentrations of CBGF samples to be tested were estimated based on their
protein content as determined by the Lowry assay. In addition, several
wells with complete medium containing 0.1 % or 1% FBS and others with
10% FBS were included as controls in each bioassay. The non-neuronal
cells were stimulated for 6 hours before 1 JlCi/well of methyl-
3H-thymidine (specific activity 50 Ci/mmole; ICN) was added for a further
24 hr stimulation/labeling period. The medium was then aspirated, the
cells were washed 2X with cold PBS, and the cells were fixed in 10%
trichloroacetic acid (TCA) for 10 minutes at 4°C. The cells were washed
with cold 5% TCA and then 2X with cold PBS; the cells were then air-dried.
The dried cells were solubilized in freshly prepared 0.5% SDS in 0.3N NaOH.
The TCA precipitable material was precipitated with 25% TCA/well for at
least 20 minutes at 4°C. The well contents were filtered through glass
fibre filters (Whatman GF/C) , washed with cold 5% TCA (2X 1 ml, IX 8 ml),
and finally rinsed with ethanol. Filters were dried and counted in 7 ml
Aqueous Counting Solution (ACS) in a Beckman scintillation counter (model
LS 1800).
B. Pronase sensitivity tests
Pronase sensitivity tests were carried out on fraction P6-3. A Lowry
protein estimation was performed and a quantity of P6-3 resulting in a
final test concentration of 30 ng/ml was used. This was incubated with
pronase at a P6-3:pronase concentration of 100:1 for 10 minutes at 37°C.
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A control employing distilled H20 in place of the P6-3 was also prepared.
These samples were then diluted in complete medium with 1% FBS to a
final concentration of 30 ng/ml P6-3 and added to the "quiescent" cells.
The remainder of the bioassay was carried out as described previously.
C. Calculation and presentation of
bioassay data of tested fractions
The biological activity of test fractions was determined using the
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bioassay as described. Fractions were tested in twenty-four well plates
with each well representing one sample. Each test plate included two
controls, 1% FBS (occasionally 0.1 % FBS) and 10% FBS. Test fractions were
added to medium supplemented with 1% FBS. Incorporated 3H-thymidine
was measured as counts per minute (cpm) on a scintillation counter.
Several replicates of each fraction were tested and the cpm values of these
were averaged. To facilitate a comparison of the effect of a given fraction
on cell growth with 1% FBS, data were calculated as percent difference
from the 1% FBS control using the following formula:
% difference = X cpm cells with test fraction - X cpm cells in 1% FBS xlOO%
from 1% FBS X cpm cells in 1% FBS
where X represents the mean of three to six replicates of a specific
treatment in the same assay. The biological activity of the test fractions is
presented in bar graph form with each treatment listed on the horizontal
axis and its effect on cell growth represented as percentage difference
from the 1% FBS control on the vertical axis. Thus, 1% FBS is depicted as
the horizontal axis of the graph, that is, 0% difference from the control.
Each graph also includes the effect of 10% FBS, a known growth stimulus.
To ascertain whether a statistically significant difference (p~0.05) existed
between the proliferative effects of anyone test treatment and 1% FBS, the
Wilcoxon Mann-Whitney U test was applied. Since the data was not
normally distributed, a non-parametric unpaired test was deemed most
suitable. A statistically significant result is graphically presented as an "x "
over the corresponding bar on the graph. All bioassay results are
presented in this manner unless otherwise specified.
Glial Fibrillary Acidic Protein Immunohistochemistry
Using the indirect immunofluorescence method, the non-neuronal
cells were tested for their expression of glial fibrillary acidic protein
(GFAP). Cells, seeded at a density of 1.2xlOS cells/dish, were cultured on
collagen-coated coverslips in 35 mm Falcon petri dishes and were used in
these studies while still subconfluent. The cells were washed with Hank's
buffered saline and then fixed in 4% paraformaldehyde-0.25 %
gluteraldehyde in O.1M cacodylate buffer for 10 minutes at 4°C. The cells
were again washed in Hank's buffered saline, the coverslips were removed,
and the cells on the coverslips were incubated with acetone for 1-2
minutes at -20°C. The washed cells were incubated with 10% FBS for 45
minutes at room temperature and washed again in Hank's buffered saline.
The cells were then incubated with a 1:500 dilution of mouse monoclonal
antibody (lgG) to pig GFAP (ICN) (1° antibody) for two hours at room
temperature; the stock anti-GFAP had been diluted with 0.1 % bovine
serum albumin (BSA)-O.l % sodium azide in Hank's buffered saline. Control
cells were incubated with the appropriate dilution of BSA in Hank's
buffered saline (no 10 antibody). After this period of time, the coverslips
were dipped in Hank's buffered saline and then washed 3X for 3 minutes
with shaking. The coverslips were then incubated with a 1: 100 dilution of
rabbit antibody to mouse IgG (2° antibody) for one hour at 37°C. The cells
were washed using the method employed in the wash following the
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incubation with the 10 antibody. The coverslips were then incubated with
a 1:100 dilution of rhodamine-labelled goat antibody to rabbit IgG (3 0
antibody) for 1 hour. A control coverslip which had been treated with
both the 10 and 20 antibodies was incubated with Hank's buffered saline
alone (no 30 antibody). The cells were again washed using the method
employed following the 10 antibody incubation. The coverslips were
mounted onto glass slides using 50% glycerol, 50% PBS with 1% (w:v)
DABCO. Using a Zeiss photomicroscope III equipped for rhodamine
epifluorescence, the coverslips were exalnined for GFAP-positive cells.
Both of the controls, in which the 10 antibody and 30 antibody were
separately omitted, revealed no detectable fluorescence.
Nuclear Magnetic Resonance Spectroscopy
The sample rp-HPLC fraction #7 was dissolved in 99.96% D20 and
placed in a micro NMR tube. A Bruker AC 200 instrument was used to
perform the 1H NMR studies. The HDO resonance line at 4.6 ppm was used
as a reference.
Fast Atom Bombardment Mass Spectrometry
FAB-MS were obtained with a KRATOS concept IS double-focusing
mass spectrometer. For normal FAB-MS, samples were dissolved in 99.5+%
glycerol (spectrophotometric grade) and transferred to the probe tip. The
probe tip used for nucleotide work was 1.5-2 mm in diameter; a mega
probe five times this size was employed in acquiring the spectra of
bombesin and rp-HPLC fraction #7. The probe was then inserted into the
FAB-MS ion source. For flow FAB-MS, the samples were dissolved in 5%
glycerol in H20 (v:v). Sample introduction occurred through a 0.075 mm
fused silica tubing which erupted 0.25 mm from the centre of the probe tip
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surface. The sample flow rate was 5-10 Ill/min at the probe tip. Under
both normal and flow FAB-MS systems, the following conditions were
employed: stainless steel targets at 8 kev acceleration potential; xenon
bombardment gas with a xenon particle energy of 7.5 Watts; spectral
range, m/z 100 to m/z 2000; resolving power, 1500. Mass calibration was
done using both perfluoroheptatriazine (about 1500 Da) and cesium iodide
as mass references.
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RESULTS
Optimization of Bioassay Conditions
The bioassay employed in this work was used to determine the
biological activity of CBGF at various levels of purity and of several
nucleotides. This involved culturing non-neuronal 10 day chick embryo
brain cells, rendering them "quiescent", adding the factor to be tested, and
later adding 3H-thymidine. Cell proliferation in response to the exogenous
factor was indirectly measured using a scintillation counter to determine
radioactive label uptake into the cells' DNA.
The first goal of this research was to partially characterize and
optimize the culture and assay conditions of this system. The systematic
study of these parameters had not been done previously.
Culture Conditions
A . Collagen-coated versus uncoated culture dishes
Initially, non-neuronal cell growth on collagen-coated and uncoated
culture dishes was qualitatively examined.
Cells plated onto collagen-coated culture dishes readily adhered and
flattened. This was not the case for the cells placed in uncoated dishes. At
confluence of primary cultures on collagen-coated plates, cells plated at an
equal density on uncoated plates were extremely sparse. After the first
sub-culture of cells which had been grown on collagen-coated dishes, those
cells plated on uncoated dishes took longer to adhere and flatten. Despite
growing faster as first passage cells than as primary cultures, non-
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neuronal cells on uncoated dishes were consistently more sparse than their
counterparts plated onto -collagen-coated dishes.
B. Responsiveness of different subcultures
of non-neuronal cells to 10% FBS
Throughout the course of this research, each bioassay performed
included two controls: one in which cells were at a low basal level of
growth in medium supplemented with 0.1 % or 1% fetal bovine serum (FBS)
and the second in which cells were at nearly maximal growth in medium
supplemented with 10% FBS. The percent difference of 3H-thymidine
incorporation in cells treated with 10% FBS with respect to those treated
with the basal level of FBS was calculated as:
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% Difference from
low FBS control
= X cpm cells in 10% FBS - X cpm cells in low FBS xlOO%
X cpm cells in low FBS
where X represents the mean of three to six replicates of a given treatment
in the same assay and cpm represents counts per minute as determined by
the 3H channel of a Beckman scintillation counter.
The percent difference of 10% FBS from the low FBS control was used
as a measure of the cells' ability to respond to a known proliferative
growth stimulus (ie. 10% FBS). Data from assays employing the 1% FBS
control were used to compare the responsiveness of the non-neuronal cells
at each subculture within every cell preparation. Employing Wilcoxon one-
tailed and two-tailed paired-sample tests (Zar, 1984), it was found that
first subculture cells were less responsive to stimulation than second
subculture cells derived from the same cell isolation (0.02< p <0.05). No
difference in the ability to stimulate second subculture and third
subculture cells was detected using this statistical test (p=O.l). Several
assays in which fourth subculture cells were tested showed no statistical
difference (using the Wilcoxon Mann-Whitney U test) between the 1% and
10% FBS controls. The results of such assays were discounted. Thus, a
comparison of third and fourth subculture cells by the Wilcoxon paired
sample test could not be made since the remaining sample size was
insufficient.
c. Effects of medium components on non-neuronal cell growth
The maintenance of non-neuronal cell cultures in this laboratory had
relied upon the use of a supplemented undefined medium consisting of an
alpha minimal essential medium (a-MEM) base with fetal bovine serum
(FBS) , 33.3 mM D-glucose, 1 x antibiotic/antimycotic, 5 Ilg/ml insulin,
3 x 10- 8 M sodium selenate, 5 J-lg/ml transferrin, 100 11M putrescine, and
2 x 10- 8 M progesterone (Carlone et al., 1987). The individual effects of
some of these additives on 3H-thymidine incorporation in these cells was
investigated.
Non-neuronal cells were grown in 10% FBS in a-MEM supplemented
with glucose and antibiotic/antimycotic. They were then rendered
quiescent in the same medium with 0.1 % FBS rather than 10% FBS. Insulin,
sodium selenate, transferrin, putrescine, and progesterone were
individually added to 0.1 % FBS a-MEM and separately tested on the cells.
Since the progesterone had been dissolved in ethanol, a control of 0.05%
ethanol was included in the assay. The assay was performed twice, each
with three replicates of the test substances. (In plate B, only two
replicates of the 0.05% ethanol treated cells were used). The results are
presented in Figure 1. A Wilcoxon Mann-Whitney U test (Zar, 1984) was
applied to the data to find that, in both plates, 10% FBS and sodium
selenate significantly stimulated 3H-thymidine incorporation in the cells.
For 10% FBS, this increase was 406.6% to 414.2% and for sodium selenate
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Figure 1. Effects of Various Medium Components on 3H-thymidine
Incorporation in Two 24-well Plates of Cultured Chicl\:
Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 0.1 %
FBS control for each treatment on each of plates A (solid
bars) and B (hatched bars). Statistically significant
differences (psO.05) are represented by an "x" over the
corresponding bar on the graph. Etoh denotes ethanol,
used to dissolve the progesterone and as an assay control.
n = 3 for each test substance except plate B Etoh where
n = 2. (FBS = fetal bovine serum)
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it was 28.0% to 63.7% over the 0.1 % FBS control. In plate B, insulin was
found to affect a 60.1 % increase in radiolabel uptake. Progesterone was
found to be inhibitory (-41.9%) from the results of plate B. Conflicting
responses were noted for the addition of 0.05% ethanol which was
inhibitory (-27.5%) to growth in the cells of plate A, but stimulatory
(26.3%) to the cells of plate B. All other medium additives had no
statistically significant effect on the cells.
A comparison of incomplete medium containing only the a-MEM, FBS,
glucose, and antibiotic/antimycotic and complete medium containing the
aforementioned ingredients as well as each of the additives insulin, sodium
selenate, transferrin, putrescine and progesterone was made. The percent
difference of 10% FBS from 0.1 % FBS was utilized to contrast five replicates
of complete and six replicates of incomplete medium. One-tailed and two-
tailed Mann-Whitney U tests indicated that the complete medium
significantly stimulated 3H-thymidine incorporation above that observed
for cells treated with incomplete medium (psO. 05).
D. Response of non-neuronal cells to 0.1 % and 1 % FBS
At the outset of this research, medium supplemented with 0.1 % FBS
was used to render the non-neuronal cells "quiescent" and to serve as the
base to which cell test factors were added. A low percentage of FBS was
expected to keep the cells viable and growing at a slow rate, while
permitting the difference between the cells' response to 0.1 % FBS and 10%
FBS to be maximized. Each assay included a control in which only 0.1 %
FBS, without an additional test factor, was added to the cells.
Incorporation of 3H-thymidine in these controls was very low. Moreover,
in a bioassay in which cells were tested with 0%, 0.1%, 1%, and 10% FBS,
cells in the presence of 0% and 0.1 % FBS appeared less healthy, with
greater cell death occurring, than cells treated with either 1% or 10% FBS.
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The percent difference in 3H-thymidine incorporation in cells tested with
10% PBS over those in 0.1 % FBS was 515.3%, while the percent difference
of cells in 10% FBS over those in 1% FBS was 393.0%. Although one of the
goals of quiescence is the maximization of the difference between cell
growth in the "quiescent" state and in 10% FBS, use of 1% FBS instead of
0.1 % FBS, for this purpose was deemed more suitable in light of its positive
effect on non-neuronal cell health.
Assay Conditions
A . The effect of varying the duration of "quiescence n
Non-neuronal cells were grown in complete medium supplemented
with 10% FBS; this allowed the cells to proliferate. Before the cells could
respond to stimulation by a test factor, it was necessary to decrease their
rate of growth, that is to say, to render them "quiescent". True quiescence
is a state in which the cells remain viable but do not divide. The non-
neuronal cells in this laboratory were found to be visibly "healthier" in a
medium supplemented with FBS. Therefore, when the cell culture medium
was changed from 10% PBS to 0.1 % or 1% FBS, the cells were not rendered
truly quiescent, but were growing at a basal level. This step in the
bioassay permitted the difference between the cells' response to 10% FBS
and 0.1 % or 1% FBS to be maximized. A test substance could then be added
to 0.1 % or 1% FBS to determine the cells' reaction to it.
The optimum length of "quiescence" was studied using 1% FBS.
Individual 35 mm culture dishes had varying quiescence durations from
three to seventy-two hours (Figure 2), with each time having four
replicates. Incorporation of the 3H-thymidine was highest at three hours,
decreased by six hours, and was at a constant level by 14.5 hours. This
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Figure 2. The Effect of the Duration of "Quiescence" Time on
3H-thymidine Incorporation in Cultured Chick Embryo
Brain Non-neuronal Cells.
Data are presented as means ± standard deviation of the
incorporated 3H-thymidine in cpm for each time tested,
where n = 4. Cells were rendered "quiescent" in 1% FBS
for varying lengths of time, followed by a constant 24 hr.
prestimulation time in 10% FBS and a subsequent
constant 24 hr. labelling time. (cpm = counts per minute;
FBS = fetal bovine serum)
Figure 3. The Effect of the Duration of "Prestimulation" Time on
3H-thymidine Incorporation in Cultured Chick Embryo
Brain Non-neuronal Cells.
Data are presented as means ± standard deviation of the
incorporated 3H-thymidine in cpm for each time tested,
where n = 4. Cells were rendered "quiescent" in 1% FBS
for a constant 24 hr. period, followed by a prestimulation
time of varying lengths in 10% FBS and a subsequent
constant 24 hr. labelling time. (cpm = counts per minute;
FBS = fetal bovine serum)
Figure 4. The Effect of the Duration of 3H-thymidine Labelling
Time on 3H-thymidine Incorporation in Cultured Chick
Embryo Brain Non-neuronal Cells.
Data are presented as means ± standard deviation of the
incorporated 3H-thymidine in cpm for each time tested,
where n = 4. Cells were rendered "quiescent" in 1% FBS
for a constant 24 hr. period, followed by a constant 24 hr.
prestimulation time in 10% FBS and a subsequent
labelling time of varying length. (cpm = counts per
minute; FBS = fetal bovine serum)
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constant level of cell growth was maintained until the last test time of
seventy-two hours "quiescence". It appeared that at three and SIX hours of
quiescence, the cells were continuing to respond to residual effects of
having been in 10% FBS. By 14.5 hours, the difference between growth in
1% and 10% FBS had reached a maximum which was maintained until at
least seventy-two hours. Twenty-four hours "quiescence" fell in this
constant range and was employed in future assays as a convenient length
of time. For the "quiescence" time course study, constant 24 hour
stimulation and labelling times were used.
B. The effect of varying stimulation time
Following the time of "quiescence", the non-neuronal cells of this
bioassay were at a low level of growth and ready to respond to a growth
stimulus. It was at this point in time that a l<:nown concentration of a test
substance was mixed with 0.1 % or 1% FBS and added to the cells so that its
effect on their proliferation might be determined. Since the cells were
initially grown in medium supplemented with 10% FBS, this was known to
be an effective growth stimulus with which to study the optimum length of
stimulation.
Individual 35 mm culture dishes were each rendered "quiescent" In
1% FBS for a constant time of 24 hours. After this, 10% FBS was added to
the dishes, however the duration of "prestimulation", without added
radioactive label, was varied from three to ninety-six hours (Figure 3),
with each time represented with four replicates. A constant labelling time
of 24 hours ensued. Incorporation of 3H-thymidine increased to a high at
six hours of prestimulation. This was followed by an initial rapid decrease
in label incorporation to twelve hours and then a lower rate of decline to
ninety-six hours of prestimulation. It appeared that the non-neuronal
cells of this study required approximately six hours of contact with 10%
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FBS without added 3H-thymidine before the cells could achieve a
maximum stimulation response. Since there is a decline in growth after
this time, it is possible that the proliferating cells are depleting the
medium of the stimulus. As a result, a six hour period of prestimulation
was employed in. future assays. It should be noted that this optimal
stimulation time may apply specifically to treatment with 10% FBS and
could conceivably differ for treatment with other substances such as those
used in this research.
c. The effect of varying labelling time
In order for the degree of growth caused by a given test factor to be
determined, it was necessary to have a method of detecting newly formed
cells. For this reason, a radioactive label that would incorporate into
proliferating cells was required. 3H-thymidine was added to the medium
after the initial stimulation period. By adding a labelled nucleoside to the
non-radioactive nucleoside pool, proliferating cells undergoing DNA
replication incorporated these components into their DNA and were
marked. The extent of 3H-thymidine incorporation, and thus DNA
synthesis, was then determined as counts per minute in a scintillation
coun ter.
The optimum length of labelling was studied. Individual 35 mm
culture dishes were each rendered "quiescent" in 1% FBS for a constant
time of 24 hours. This was followed by a constant 24 hour unlabelled
stimulation period with 10% FBS. At this time, 3H-thymidine was added to
the medium as stimulation continued. The labelling time was varied from
three hours to forty-eight hours (Figure 4), with each time represented by
four replicates. Incorporation of 3H-thymidine appeared to increase
linearly from three to forty-eight hours of labelling. Therefore, the non-
neuronal cells incorporate more 3H-thymidine the longer they are exposed
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to it. A twenty-four hour labelling time was chosen as a convenient time
which was employed in future assays.
Sumnlary of Optimunl Cell Culture and Bioassay Conditions
A summary of the optimum cell culture and bioassay conditions can
be found in Table II. Collagen-coated, rather than uncoated culture dishes
promoted faster, more extensive non-neuronal cell growth, particularly for
primary cells. The most growth responsive cell culture ages were the
second and third subcultures. Complete growth medium containing insulin,
sodium selenate, transferrin, putrescine, and progesterone in addition to a-
MEM, FBS, glucose, and antibiotic/antimycotic allowed the best non-
neuronal cell growth. Medium supplemented with 1% FBS, as opposed to
0.1 % FBS, used for rendering the cells quiescent and as a base for the test
factors was found to give healthier non-neuronal cells. The most effective
bioassay conditions included a minimum 14.5 hour "quiescence" time
(24 hours was adopted), a 6 hour stimulation time, and a 24 hour
3H-thymidine labelling time.
Cell Culture Composition
An attempt was made to characterize the chick embryonic brain cell
composition using the technique of immunohistochemistry. The cultured
cells utilized in this research had the distinctive cobblestone morphology
attributed to confluent astroblasts (astrocyte precursors) previously
observed in this laboratory (Carlone eta al., 1988) and by others in the
chicl( embryo (McCarthy and Partlow, 1976) and new born mouse
(Sensenbrenner and Mandel, 1974). Astrocytes are characterized by
intermediate glial filaments in their cytoplasm; these fibres consist of glial
fibrillary acid protein (GFAP) and antibodies against it may be used to
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Table II. Sutnm.ary of Optim.uIn Cell Culture and
Bioassay Conditions
Cell Culture Conditions
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collagen-coated vs. uncoated culture dishes
cell subculture
cOlllplete vs. incomplete m.ediulll
1% vs. 0.1% FBS for assay control
Bio-Assay Conditions
"quiescence" time
stilllulation titne
3
H-thynlidine labelling tillle
collagen-coated
nd rd
2 or 3
cOl11plete
1%
tninitnum 14.5 hr
(24 hr used)
6hr
24hr
identify astrocytes. Subcultured confluent non-neuronal chick embryo
brain cells have been found to be composed of >90% GFAP positive cells
when tested one week after plating (Carlone eta al., 1988). In this study,
preliminary evidence indicated that primary non-neuronal cells tested
4 days after plating while cells were subconfluent, consisted of 6.63% GFAP
positive cells (several GFAP positive non-neuronal cells showing clear
cytoplasmic staining are apparent in Figure 5). These results represent the
mean percentage of GFAP positive cells in two fields of view with a total of
581 cells counted. These apparently conflicting results suggest that the
cells used in this research were composed primarily of astroblasts; these
precursors do not stain for GFAP (Pixley et al., 1984).
Isolation and Purification of Chicl< Brain Growth Factor
A . Changes to the isolation and purification procedure
The isolation of chick brain growth factor (CBGF) has been described
previously (Carlone eta al., 1985; 1987). The brains of ten to twenty dozen
eighteen day chicl{ embryos are removed, homogenized, and centrifuged at
100,000 x G. The supernatant undergoes ultrafiltration by passing it
through a series of Amicon filters of decreasing porosity: a PM-30
membrane of nominal molecular weight cut-off 30,000 Daltons (Da.) and a
YM-2 membrane of nominal molecular weight cut-off 2,000 Da. In each
case, the filtrate is used for the proceeding step. At this point, the isolation
procedure employed in this research diverges from that outlined by
Carlone eta al. (1985, 1987). Previously, the YM-2 filtrate was applied to a
UM-05 membrane (nominal molecular weight cut-off of 500 Da.) and the
retentate was collected. Amicon ceased manufacture of this membrane,
made of a blend of polyelectrolytes, and replaced it with a cellulose YC-05
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Figure 5. Glial Fibrillary Acidic Protein (GFAP)
Immunofluorescence of Cultured Primary 10-day Chick
Embryo Brain Non-neuronal Cells.
Immunofluorescence processing of the cells is described
in the text. x250.
I
. I
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membrane, having a molecular weight cut-off of 300 to 400 Da. . Prior to
this study, several attempts were made to isolate an active fraction from
the YC-05 retentate, but these efforts failed. The YM-2 filtrate was also
applied to a Biogel P2 size exclusion column (with molecular weight cut-off
of 2,000 Da.); however, no separation of the material resulted, with only
one peak eluting. Consequently, in this research, the YM-2 filtrate was
applied to a Biogel P6 size exclusion column (with molecular weight cut-off
of 6,000 Da.) from which a biologically active fraction was collected. Use of
a DEAE anion exchange column was discontinued, as it had been in a
previous study (Seifried, honours thesis, 1988). Anion exchange high
performance liquid chromatography was used to separate the P6 fraction,
but difficulties in testing the resultant fractions caused this technique to be
abandoned. The subsequent purification step was reverse phase high
performance liquid chromatography (rp-HPLC). The CBGF isolation
procedure was undertaken four times during the course of this worl<:.
B. Biological activity of ultrafiltration fractions
After the brain homogenate was centrifuged at 100,000xG, it was
passed through an Amicon PM-30 membrane having a molecular weight
cut off of 30,000 Da. The biological activity of the PM-30 filtrate was
determined using the non-neuronal cell bioassay. In Figure 6, the effects
of various concentrations of the PM-30 filtrate, as well as the 10% FBS
control, on 3H-thymidine incorporation in third passage non-neuronal cells
are given. As can be seen, 10 Jlg/ml PM-30 filtrate significantly stimulates
3H-thymidine uptake in these cells, causing a 33.8% Increase over the
control. A concentration dependence of the PM-30 filtrate on cell growth
was displayed since the lower concentrations (1 Jlg/ml and 100 ng/ml)
elicit decreasing amounts of growth stimulation. The stimulation seen at
1 Jlg/ml and 100 ng/ml PM-30 filtrate was not statistically significant. As
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Figure 6. Effect of PM-30 Filtrate on 3H-thymidine Incorporation
in Cultured Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the PM-30 filtrate concentrations
tested and the 10% FBS control. Statistically significant
differences (psO.05) are represented by an fiX It over the
corresponding bar on the graph. n = 6 for each PM-30
filtrate test concentration; n = 3 for the 1% and 10% FBS
controls. Third subculture cells were used. (FBS = fetal
bovine serum)
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was expected, 10% FBS gave a significant increase in cell growth with a
117.2 % difference over control.
Once it had gone through the PM-30 membrane, the filtrate was
passed through an Amicon YM-2 membrane having a molecular weight
cut-off of approximately 2,000 Da. A compilation of data from two
bioassays of the YM-2 filtrate is represented in Figure 7; YM-2 filtrate
concentrations of 4 Ilg/ml, 400 ng/ml, and 40 ng/ml were tested on first
subculture cells in one twenty-four well plate, while concentrations of
10 J,lg/ml, 1 Jlg/ml, and 100 ng/ml were tested on second subculture cells
in the second plate. As can be visualized in Figure 7, the YM-2 filtrate was
effective at causing an increase in 3H-thymidine uptake, with maximum
stimulation at 1 J,.lg/ml. This treatment resulted in a statistically significant
increase of 34.0% over the control. a-nee again growth stimulation in these
cells was dependent on the YM-2 filtrate concentration used, with a bell-
shaped concentration dependence apparent. Both high (10 Ilg/ml) and low
(10 ng/ml and 40 ng/ml) concentrations of the YM-2 filtrate had no
significant effect on cell growth, with intermediary concentrations (4 Ilg / m I
and 400 ng/ml) having a diminished significant stimulatory effect. The
value of 84.9% increase over control given for 10% FBS is the mean
determined from the 80.7% increase of the first assay (n=4) and the 89.0%
increase of the second assay (n=4).
c. Elution profile and biological activity of biogel P6 fractions
Following ultrafiltration, the YM-2 filtrate was lyophilized,
reconstituted in a small volume of distilled water (approximately 1 ml)
and applied to a Biogel P6 size exclusion column (molecular weight cut-off
of 6,000 Da.). The fractions were collected at ten minute intervals at a flow
rate of 0.165 ml/min with a resultant fraction volume of 1.65 mI. The
ultraviolet (UV) absorbance of these fractions was measured at 260 nm
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Figure 7. Effect of YM-2 Filtrate on 3H-thymidine Incorporation in
Cultured Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the YM-2 filtrate concentrations tested
and the 10% FBS control. Statistically significant
differences (psO.05) are represented by an "x" over the
corresponding bar on the graph. Data have been
combined from two YM-2 filtrate bioassays. YM-2
filtrate concentrations of 4 Ilg/ml, 400 ng/ml, and
40 ng/ml were tested on first subculture cells on one 24
well plate, while concentrations of 10 Ilg/ml, 1 Ilg/ml, and
100 ng/ml were tested on second subculture cells on a
second plate; the value for 10% FBS is the mean
determined from the two plates. For each plate, n = 5 for
each YM-2 filtrate test concentration and the 1% FBS
control; n = 4 for the 10% FBS control. (FBS = fetal bovine
serum)
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(nucleotide absorbance) and 280 nm (tyrosine and tryptophan
absorbances) and was plotted as a function of test tube fraction number.
Over the course of this research, four distinct CBGF preparations were
undertaken, and similar Biogel P6 elution profiles resulted. Figure 8
provides a representative elution profile from the third CBGF preparation.
As can be seen in Figure 8, three poorly resolved UV absorbing peaks were
obtained. The first peal<:, P6-2 (tube numbers 17 to 27), contained
relatively equal amounts of components absorbing at 260 nrn and 280 nrn.
The second peak, P6-3 (tube numbers 28 to 31), was comprised of greater
260 nm than 280 nrn absorbing components, as was also the case for the
smaller third peak, P6-4 (tube numbers 32 to 41).
The biological activity of various concentrations of each of these
three fractions on non-neuronal cells was determined. From Figure 9a and
b, it can be seen that fraction P6-2 was not mitogenic. However, at
3 Ilg/ml this fraction was inhibitory to growth, causing a statistically
significant decrease of 55.7% in 3H-thymidine incorporation. The fraction
also caused a slight decline in growth at 30 ng/ml (significant in the first
bioassay). In Figure 9a, 10% FBS effected a 65.1 % increase in growth, while
in Figure 9b a 117.0% increase was found. Variations in the non-neuronal
cells' response to this known growth stimulus are also reflected in the cells'
ability to respond to test factors. Thus, the cells of the bio-assay
represented in Figure 9a were less responsive to 10% FBS than the first
subculture cells of the assay depicted in Figure 9b; concomitantly, this
decrease is mirrored in Figure 9a cells treated with 300 ng/ml and
30 ng/ml P6-2 compared to similarly treated cells in Figure 9b.
The graph of Figure 10 represents a compilation of data from two
bioassays of P6-3 on second passage non-neuronal cells; P6-3
concentrations of 3 Ilg/ml, 1 Ilg/ml, and 300 ng/ml were assayed on one
twenty-four well plate, while P6-3 concentrations of 100 ng/ml, 30 ng/rnl,
and 3 ng/ml were assayed on the second plate. The value of 143.3%
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Figure 8. Biogel P6 Elution Profile of YM-2 Filtrate Fractionation.
A Biogel P6 size exclusion column (nominal molecular
weight cut-off of 6,000 Da.) was used to separate the
concentrated YM-2 filtrate into three peaks labelled P6-2
(fractions 17-27: red), P6-3 (fractions 28-31: blue), and
P6-4 (fractions 32-41: yellow). Fractions were eluted
with 0.05 M ammonium acetate and collected at 10
minute intervals, yielding 1.65 ml fraction volumes.
Samples from the individual fractions were diluted 100x
and UV absorbances were measured at 280 nm (dotted
line) and 260 nrn (solid line).
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Figure 9. Effect of P6-2 on 3H-thymidine Incorporation in Cultured
Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the P6-2 concentrations tested and the
10% FBS control. Statistically significant differences
(p~O.05) are represented by an "x" over the
corresponding bar on the graph. n = 4 for each P6-2 test
concentration and the 1% and 10% FBS controls.
(FBS = fetal bovine serum)
A: P6-2 concentrations tested: 3 J.[g/ml, 300 ng/ml,
30 ng/ml, and 3 ng/ml. First subculture cells were used.
B: P6-2 concentrations tested: 1 Jlg/ml, 300 ng/ml,
100 ng/ml, and 30 ng/ml. First subculture cells were
used.
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Figure 10. Effect of P6-3 on 3H-thymidine Incorporation In Cultured
Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the P6-3 concentrations tested and the
10% FBS control. Statistically significant differences are
represented by an "x" over the corresponding bar on the
graph. Data have been combined from two P6-3
bioassays on second subculture cells in which P6-3 test
concentrations of 3 Ilg/ml, 1 Ilg/ml, and 300 ng/ml were
tested on one culture plate and 100 ng/ml, 30 ng/ml, and
3 ng/ml were tested on the second culture plate; the
value for 10% FBS is the mean determined from the two
plates. For each plate, n = 6 for each P6-3 test
concentration; n = 3 for the 1% and 10% FBS controls.
(FBS = fetal bovine serum)
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increase over control given for 10% FBS is the mean determined from the
172.8% increase of the first assay (n=4) and the 113.7% increase of the
second assay (n=4). The biological activity of fraction P6-3 displayed a
concentration dependence over the range 3 J.lg/ml to 3 ng/ml with high
concentrations of this material being inhibitory and lower concentrations
being stimulatory to cell growth. At 3 J.lg/ml, P6-3 caused a statistically
significant 32.2 % inhibition of 3H-thymidine incorporation in these non-
neuronal cells. This fraction produced no effect at 1 J.lg/ml, 300 ng/ml and
100 ng/ml. At a concentration of 30 ng/ml, fraction P6-3 gave a
significant 32.3% increase in cell proliferation. At 3 ng/ml, the increase in
cell growth had diminished to 26.2 %, but was still a statistically significant
effect.
Fraction P6-4 was found not to cause cell proliferation and was in
fact inhibitory at high concentrations. From Figure 11, one can see that
P6-4 caused a statistically significant 39.2% decrease in growth as
compared to the control when tested at 1 J.lg/ml. No effect was generated
when the cells were treated with 100 ng/ml, 10 ng/ml or 1 ng/ml of P6-4.
The 10% FBS caused a significantly stimulatory response of 70.8%.
D. Elution profile and biological activity
of anion exchange HPLC fractions
Previous studies had indicated that the mitogenic activity resided in
a polar molecule. This was evidenced by the elution of HPLC fractions
under an isocratic solvent system of H20 with 0.05% trifluoroacetic acid
(TFA) or 0.1 % acetonitrile (CH3CN) in H20 with 0.05% TFA (Seifried, honours
thesis, 1988). For this reason, it was thought that fractionation of the
material in the P6-3 fraction should be based on charge. With this
intention, anion exchange HPLC was attempted. The elutions profiles at
280 nm, 256 nm and 229 nm obtained from a separation of fraction P6-3
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Figure 11. Effect of P6-4 on 3H-thymidine Incorporation in Cultured
Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the P6-4 concentrations tested and the
10% FBS control. Statistically significant differences
(p~0.05) are represented by an "x" over the
corresponding bar on the ~raph. n = 4 for each P6-4 test
concentration and the 1% and 10% FBS controls. Third
subculture cells were used. (FBS = fetal bovine serum)
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are presented in Appendix A. Approximately seven peaks were apparent.
Each of the seven fractions identified in the elution profile at 256 nm were
tested for their ability to stimulate non-neuronal cell growth. Since the
column was run under a gradient employing solutions with high
concentrations of KHzP04 and KCI (0.1 % O.007M KHzP04 and 0.007M KCI pH
4.0 to 99.9% 0.25M KHzP04 and 0.50M KCI pH 5.0 in 20 minutes), the
eluted samples also contained large amounts of these salts. Consequently,
it was necessary to test a salt control corresponding to the KHzP04 and KCI
content of each fraction at every concentration examined. Appendix A
contains the results of such assays. Data are presented in bar graph form
in which the mean incorporation of 3H-thymidine in cpm is given for each
treatment. Thus, the value for 3H-thymidine incorporation for the 1% FBS
control is also given, since these results are not presented as a percentage
from the control. To accommodate every test condition for four
concentrations of each anion exchange HPLC fraction, two twenty-four well
bioassay plates were used per fraction.
When compared to their corresponding salt controls, it was found
that anion exchange HPLC fraction #2 at 200 ng/ml and 2 ng/ml and
fraction #5 at 30 ng/ml were biologically active. These results were
confounded by the fact that the salt controls were found to cause more
3H-thymidine incorporation than their corresponding test factor in fraction
#2 at 20 ng/ml and 0.2 ng/ml. In these instances, the salt controls were
found also to be mitogenic compared to the 1% FBS control. Furthermore,
high concentrations of these salts were found to be inhibitory to non-
neuronal cell growth. Such variable results and conditions were not
deemed suitable for accurately determining the mitogenic status of these
fractions. Moreover, the high KHzP04 and KCI concentrations made it
difficult to estimate the protein content of the fractions using the Lowry
protein assay. In fact, upon addition of the Folin reagent, a white
precipitate formed. This was removed following centrifugation, however
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potential interference with the reaction itself or in the absorbance readings
rendered these protein determinations unreliable. Due to these severe salt
effects, use of anion exchange HPLC as a purification step in this procedure
was discontinued.
E. Elution profile and biological activity
of reverse phase HPLC fractions
As a means to further purify the biologically active material, fraction
P6-3 was lyophilized, reconstituted in a small volume of distilled water,
and subjected to Cl 8 reverse phase high performance liquid
chromatography (rp-HPLC). The elution was accomplished under a
relatively steep gradient of 0.1 % to 99.9% CH3CN in H20 with 0.05% TFA in
twenty minutes; an initial two minute period of isocratic 0.1 % H20 with
0.05% TFA followed by the gradient was also effective. A typical reverse
phase HPLC elution profile recorded at 280 nm is given in Figure 12. As
can be seen, eleven ultraviolet absorbing peaks were observed. Figure 13
shows the rp-HPLC elution profile recorded at 256 nm, a wavelength
typically associated with nucleic acid absorbance. While it is not possible
to directly compare the rp-HPLC elution profiles of Figures 12 and 13 since
different concentrations of fraction P6-3 were loaded onto the column, an
examination of relative peal( heights is possible. Thus, it is apparent that
peak 6 appeared to have increased proportionately more than the others.
This is particularly evident when comparing the similar peak heights of
peaks 4 and 6 in Figure 12 to the notable increase in the height of peak 6
in Figure 13. Although the height of peak 1 is smaller in Figure 13 than in
Figure 12, the height of this peal( at 280nm was inconsistent throughout
the numerous rp-HPLC elutions which were performed. Each of the
eleven peal(s was tested in the bioassay for its effect on non-neuronal cell
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Figure 12. RP-HPLC Elution Profile of P6-3 Fractionation
Monitored at 280 nm.
A I-lBondapak Cl 8 column was used to separate the
concentrated Biogel P6-3 fraction into eleven peaks,
which were individually collected. The fractions were
eluted with a gradient of 0.1 % to 99.9% CH3CN in H20 with
0.05% TFA in 20 minutes. (RP-HPLC = reversed phase
high-performance liquid chromatography;
TFA = trifluoroacetic acid)
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Figure 13. RP-HPLC Elution Profile of P6-3 Fractionation
Monitored at 256 nm.
A J.lBondapak Cl 8 column was used to separate the
concentrated Biogel P6-3 fraction. The peaks were eluted
with a gradient of 0.1 % to 99.9% CH3CN in H20 with 0.05%
TFA in 20 minutes. (RP-HPLC = reversed phase high-
performance liquid chromatography; TFA =
trifluoroacetic acid)
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growth. Three concentrations of every fraction were examined:
100 ng/ml, 10 ng/ml and 1 ng/ml.
In Figure 14a, it can be seen that rp-HPLC fraction #1 at 10 ng/ml
caused a significant 23.7% increase in 3H-thymidine incorporation over the
1% FBS control. While it was stimulatory at this concentration, this was not
the case at 100 ng/ml and 1 ng/ml where no effect was apparent. A dose-
dependent response was observed over the three tested concentrations. In
this assay, 10% FBS significantly stimulated a 118.5% increase in
3H-thymidine uptake in these cells.
Figure 14b depicts the results found in the bioassay of rp-HPLC
fraction #2. This material had no effect on 3H-thymidine incorporation in
the non-neuronal cells at any of the three concentrations tested. The 10%
FBS control registered a statistically significant increase in cell growth of
66.1 %.
Like rp-HPLC fraction #2, rp-HPLC fraction #3 did not cause a change
in 3H-thymidine uptake when compared to control cells treated with 1%
FBS (Figure 14c). However, 10% PBS affected a significant 83.8%
stimulation of non-neuronal cell growth in this assay.
In contrast, rp-HPLC fraction #4 was actually inhibitory to non-
neuronal cell growth causing a statistically significant 21.3% decrease in
3H-thymidine uptake when tested at 100 ng/ml (Figure 15a). This fraction
caused no effect on cell growth when administered at 10 ng/ml or 1 ng/ml.
Treatment with 10% FBS resulted in significant 96.5% stimulation of cell
proliferation.
Similarly, rp-HPLC fraction #5 also caused significant inhibition of
non-neuronal cell proliferation (Figure 15b). Exposing the cells to
100 ng/ml this fraction resulted in an even greater decrease in 3H-
thymidine incorporation (-55.4%) than that caused by rp-HPLC fraction #4.
No effect on cell growth was seen when this fraction was tested at
Figure 14. Effect of rp-HPLC Fractions #1, 2, and 3 on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the rp-HPLC fraction concentrations
tested and the 10% FBS control. Statistically significant
differences (psO.05) are represented by an "x" over the
corresponding bar on the graph. n = 5 for each rp-HPLC
fraction test concentration and the 1% FBS control;
n = 4 for the 10% FBS control. First subculture cells were
used. (rp-HPLC = reversed-phase high-performance
liquid chromatography; FBS = fetal bovine serum)
A: Results for rp-HPLC fraction #1.
B: Results for rp-HPLC fraction. #2.
C: Results for rp-HPLC fraction #3.
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Figure 15. Effect of rp-HPLC Fractions #4, 5, and 6 on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the rp-HPLC fraction concentrations
tested and the 10% FBS control. Statistically significant
differences (p~0.05) are represented by an "x" over the
corresponding bar on the graph. n = 5 for each rp-HPLC
fraction test concentration and the 1% FBS control;
n = 4 for the 10% FBS control. (rp-HPLC = reversed-phase
high-performance liquid chromatography; FBS = fetal
bovine serum)
A: Results for rp-HPLC fraction #4. First subculture cells
were used.
B: Results for rp-HPLC fraction #5. Second subculture
cells were used.
C: Results for rp-HPLC fraction #6. Second subculture
cells were used.
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10 ng/ml and 1 ng/ml. A significant 55.4% increase in label uptake in
these cells was caused by 10% FBS.
As evidenced in Figure 15c, rp-HPLC fraction #6 promoted
3H-thymidine incorporation in the non-neuronal cells; when tested at
10 ng/ml, a significant 21.3% increase was noted. The response displayed
a bell-shaped concentration dependence. The increases in cell growth seen
at 100 ng/ml and 1 ng/ml were not statistically significant. Supplying the
cells with 10% FBS yielded a significant 45.5% increase in cell proliferation.
When rp-HPLC Fraction #7 was tested on the non-neuronal cells at
100 ng/ml, it caused a statistically significant 29.1 % inhibition of
3H-thymidine incorporation (Figure 16a). Interestingly, this same fraction
at 10 ng/ml produced a significant stimulation in cell proliferation, with an
observed 56.4% increase. This stimulation of growth over and above the
1% FBS control level was as high as that observed for 10% FBS (60.6%) in
this assay. In fact, a Wilcoxon Mann-Whitney U test applied to this data
indicated that there was no statistically significant difference between the
mitogenic effects of rp-HPLC fraction #7 at 10 ng/ml and 10% PBS. At
1 ng/ml, rp-HPLC fraction #7 had no effect on cell growth. As can be seen,
the response of the cells to rp-HPLC fraction #7 was dose-dependent, with
a bell-shaped concentration dependence.
Although treatment with rp-HPLC fraction #8 at 100 ng/ml
registered a 55.1 % inhibition of 3H-thymidine uptake and 10 ng/ml and
1 ng/ml of this material caused 24.1 % and 10.4% increases respectively,
none of these results were significantly different from the 1% FBS control
(Figure 16b). This may have, in part, been due to a large variation in the
cpm values obtained for 3H-thymidine incorporation in the 1% FBS control
of this particular assay. On the other hand, 10% FBS affected a significant
54.9% stimulation of cell. growth.
Rp-HPLC fraction #9 was slightly biologically active at 100 ng/ml,
causing a significant 4.8% increase in 3H-thymidine uptake (Figure 16c).
Figure 16. Effect of rp-HPLC Fractions #7, 8, and 9 on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the rp-HPLC fraction concentrations
tested and the 10% FBS control. Statistically significant
differences (p~O.05) are represented by an "x" over the
corresponding bar on the graph. n = 5 for each rp-HPLC
fraction test concentration and the 1% FBS control;
n = 4 for the 10% FBS control. (rp-HPLC = reversed-phase
high-performance liquid chromatography; FBS = fetal
bovine serum)
A: Results for rp-HPLC fraction #7. Second subculture
cells were used.
B: Results for rp-HPLC fraction #8. Second subculture
cells were used.
C: Results for rp-HPLC fraction #9. Third subculture
cells were used.
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When tested at 10 ng/ml and 1 ng/ml, however, this fraction produced no
apparent effect. A significant stimulation (32.9%) of non-neuronal cell
growth occurred upon treatment with 10% PBS.
The bioassay results represented in Figure 17a indicate that rp-HPLC
#10 had no effect on 3H-thymidine incorporation at any of the tested
concentrations. However, since exposure to 10% FBS also failed to
significantly stimulate growth, the ability of the cells of this particular
assay to respond to a growth stimulus is in question. Although the
findings of this assay may be inconclusive, the trends observed in Figure
17a may still be valid.
Another fraction displaying some biological activity was rp-HPLC
fraction #11. As evidenced in Figure 17b, at 100 ng/ml this material was
ineffective. However, it was significantly mitogenic at 10 ng/ml and at
1 ng/ml demonstrated its great~st ability to promote incorporation of
3H-thymidine with a significant 16.8% increase. The 10% FBS control
caused a significant 61.1 % stimulation of cell growth.
In summary, three of the rp-HPLC fractions were inhibitory to
3H-thymidine uptake when tested at 100 ng/ml: rp-HPLC #4, #5, and #7.
In contrast, five rp-HPLC fractions were biologically active causing
increases in 3H-thymidine incorporation in the non-neuronal cells: rp-HPLC
#9 at 100 ng/ml, rp-HPLC #1, #6, #7, and #11 at 10 ng/ml, and rp-HPLC
#11 at 1 ng/mI. Of these active fractions, rp-HPLC fraction #7 displayed
the greatest mitogenicity, being as stimulatory as 10% FBS. Yet, rp-HPLC
fraction #7 was also inhibitory at a higher concentration, indicating that it
has a very narrow concentration dependence. Figure 18 presents a
summary of the results for each rp-HPLC fraction tested at 10 ng/ml.
A final purification flow-chart showing each isolation step and the
biologically active fraction obtained is presented in Figure 19. The protocol
presented in this figure was found to be the most successful purification
procedure.
Figure 17. Effect of rp-HPLC Fractions #10 and lIon 3H-thymidine
Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the rp-HPLC fraction concentrations
tested and the 10% FBS control. Statistically significant
differences (psO.05) are represented by an "x" over the
corresponding bar on the graph. n == 5 for each rp-HPLC
fraction test concentration and the 1% FBS control;
n = 4 for the 10% FBS control. (rp-HPLC = reversed-phase
high-performance liquid chromatography; FBS = fetal
bovine serum)
A: Results for rp-HPLC fraction #10. Third subculture
cells were used.
B: Results for rp-HPLC fraction #11. Third subculture
cells were used.
A30
0
a- 20..,
c:
0
0
E 1 0
0
a-
....
Q) 0CJ
C
Q)
"-
CD
....
....
• 1 0'5
~0
• 2 0
114
B
10 % FBS
80
0
a- X....,
c: 600
0
e
0
...
.... 40
Q)
CJ
c:
Q)
...
CD
.... 20:!:
C
~0
o
10 % FBS
#10 100ng/ml #10 10ng/ml
Treatment
0% represents 1% FBS control
#11 100ng/ml #11 10ng/ml
Treatment
0% represents 1% FBS control
#10 1ng/ml
#11 1ng/ml
Figure 18. Summary of the Effects of rp-HPLC Fractions #1-11 on
3H-thymidine Incorporation in Cultured Chick Embryo
Brain Non-neuronal Cells.
The graph represents a compilation of data from
individual bioassays for each rp-HPLC fraction tested at
10 ng/ml. Data are presented as percent difference from
the corresponding 1% FBS control for each of the rp-HPLC
fractions. Statistically significant differences (p~O.05) are
represented by an fiX " over the corresponding bar on the
graph. n = 5 for each rp-HPLC fraction and the 1% FBS
control. (rp-HPLC = reversed-phase high-performance
liquid chromatography; FBS = fetal bovine serum)
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Figure 19. Optimal CBGF Purification Procedure Showing the
Biologically Active Fraction Obtained at Each Step.
20 dozen 18-day chick etnbryo brains
hotnogenization
ultracentrifugation (100,000 x G)
J supernatant
pressure ultrafiltration ~
PM-3D filtrate (notninal tnolecular weight
cut-off: 30,000 Da.)
YM-2 filtrate (notninal tnolecular weight
cut-off: 2,000 Da.)
size exclusion column: Biogel P6 fraction P6-3
analytical reverse phase high perfortnance liquid chrotnatography
(rp-HPLC) with C 18 column: rp-HPLC fraction #7
11 8
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F. Specific activity calculations
A summary of the degree of purification that was achieved is given
in Table III. Initially, 1,155 mg of protein were isolated from the
100,000xG supernatant isolated from 20 dozen chick embryo brains.
Following ultrafiltration through the PM-30 membrane, 14.2 mg of protein
remained in the filtrate. This material had a half-maximal stimulation of
3H-thymidine incorporation (EDso) in the non-neuronal cells of
5000 ng/ml. The mitogen was further purified by passing it through a
YM-2 membrane; the resultant amount of protein in the filtrate was 11.6
mg. The YM-2 filtrate had an EDso of 540 ng/ml. This represented a 9.26
fold purification over the PM-30 filtrate. After eluting the active material
from the P6 column, only 0.42 mg of protein remained. Fraction P6-3 had
an EDs 0 of 18 ng/ml and was 278 times purer than the PM-30 filtrate.
Following the final isolation step, rp-HPLC fraction #7 contained 0.02 mg of
protein and had an EDs 0 of 5.3 ng/ml. Thus, this corresponded to a final
CBGF purification factor of 943 when compared to the PM-30 filtrate.
Characterization of Chick Brain Growth Factor's
Biochemical Properties
The third goal of this research was to gain insight into some of the
biochemical characteristics of the biologically active fraction. Using the
purification procedure previously reported (Carlone et al., 1987), a low
molecular weight (approximately 1,500 Da.) fifteen amino acid peptide was
isolated. Other researchers investigating this problem have used this
method but were successful in isolating an active fraction using the UM-05
replacement membrane, YC-05 (Kim et al., 1991). Employment of this
different technique has resulted in the purification of substances identified
as guanosine 5'-monophosphate (GMP) (Kim et al., 1991) and adenosine
Table III. Sum.m.ary of the Purification of CBGF
from. Chick Em.bryo Brain
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Total ID a Purification50
Purification step Protein (Il1g) (ng/ml) factor
100,000 x G supernatant 1155
PM-30 filtrate 14.2 5000
YM-2 filtrate 11.6 540 9.26
Fraction P6-3 0.42 18 278
rp-HPLC fraction #7 0.02 5.3 943
The biological activity was purified frolll 20 dozen chick em.bryo
brains as described in the text .
a
ID 50 is the quantity of a given fraction necessary to cause
3
half-lllaxirnal stimulation of H-thyrnidine incorporation in the
non-neuronal cell bioassay outlined in the text.
The purification factor was calculated by dividing the ED50 of the
PM-30 filtrate by the EDso of the desired active fraction.
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5'-monophosphate (AMP) (Rathbone et al., 1992a) both of which were
found to be biologically active on chick embryo brain astrocytes. The
current research project, presented in this thesis, has also changed the
purification protocol. A variety of methods were used to attempt a partial
characterization of the mitogenic substance.
A. Ultraviolet absorbance spectra of CBGF, GMP, and AMP
The ultraviolet (UV) spectrum of rp-HPLC fraction #7 reconstituted
in distilled H20 was taken; the spectrum from 200 nm to 300 nm is shown
in Figure 20. A symmetrical absorbance peak was observed at 257.5 nm.
A second peak was evident at 203 nm. A peptide sample having tyrosine
and tryptophan residues would be expected to absorb UV light at 280 nm
(Scopes, 1982). Samples containing nucleic acids, on the other hand,
absorb UV light at 256 nm. The peak at 257.5 nm in the absorbance
spectrum of rp-HPLC fraction #7 indicated that a nucleoside or nucleotide
may have been present in the sample. Moreover, other researchers have
isolated both GMP and AMP using a variation of the purification procedure
employed in this work (Kim et al., 1991; Rathbone et al., 1992a) For these
reasons, the UV spectra of both GMP and AMP were also determined.
5'-GMP was dissolved in distilled water and its UV spectrum
between 200 nm and 300 nm was recorded (Figure 21). An asymmetrical
peak having a high wavelength shoulder and an absorbance peak
maximum at 252 nm was observed.
When the UV spectrum of 5'-AMP in distilled water was taken, a
symmetrical absorbance peak at 257.5 nm was found; a second peak
appeared at 208.5 nm (Figure 22).
In addition, UV spectra of the various buffer components and
solvents used in the purification of the biologically active material were
determined. Ammonium acetate, K2HP04, and KH2P04 were individually
Figure 20. Ultraviolet Absorbance Spectrum of rp-HPLC Fraction #7.
The lyophilized sample was reconstituted in distilled H20.
The spectrum was scanned from 200 nrn to 300 nrn.
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Figure 21. Ultraviolet Absorbance Spectrum of 5'-GMP.
The sample was dissolved in distilled H20. The spectrum
was scanned from 200 nm to 300 nm.
(5'-GMP = guanosine 5'-monophosphate)
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Figure 22. Ultraviolet Absorbance Spectrum of 51-AMP.
The sample was dissolved in distilled H20. The spectrum
was scanned from 200 nm to 300 nm.
(5 f -AMP = adenosine 5'-monophosphate)
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dissolved in distilled H20 and the UV spectrum of each was scanned
between 200 nm and 300 nm. Ammonium acetate displayed an
absorbance maximum at 230 nm. K2HP04 had absorbance maxima at
205 nrn and 201 nm. KH2P04 absorbed increasing amounts of UV light as
the wavelength approached 200 nm; no absorbance peak was observed
within the scan limits. Neat HPLC grade acetonitrile had a small
absorbance peak at 214 nrn. Neither the buffer salts nor the HPLC solvent
absorbed at 257.5 nrn, the wavelength at which rp-HPLC fraction #7 had
an absorbance peak.
B. Comparison of GMP and AMP
reverse phase HPLC elution profiles
In light of the identification of a biologically active fraction from the
IS-day chick embryo as GMP (Kim et al., 1991), a comparison was made
between the reverse phase HPLC elution profiles of rp-HPLC fraction #7
and 5f -GMP. Kim and his colleagues had found that their mitogenic
fraction and 5'-GMP co-eluted when tested under the same conditions.
In this current research project, fraction P6-3, the biologically active
material isolated from the Biogel P6 column elution, was applied to a Cl 8
reverse phase HPLC column for further purification. A gradient of 0.1 % to
99.9 % CH3CN in H20 with 0.05% TFA in 20 minutes was employed to elute
eleven fractions, of which rp-HPLC fraction #7 was the most mitogenic. A
typical elution profile recorded at 280 nm is shown in Figure 12. Rp-HPLC
fraction #7 eluted as a fairly sharp and symmetrical peak. From ten
replicate elution profiles, an average time for rp-HPLC fraction #7 elution
was calculated. The mean (+/- standard deviation) onset of elution of peak
#7 was 7.1 +/- 0.3 minutes; this corresponded to 35.5 +/- 1.5% CH3CN. At
its point of maximum absorbance, rp-HPLC fraction #7 eluted at
39.2 +/- 1.9% CH3CN.
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In contrast, 5'-GMP had a much different elution profile (Figure 23a
recorded at 280 nm) when eluted under identical conditions as those
employed in the isolation of rp-HPLC fraction #7. A broad peak which
began eluting at 11.8 minutes or 59.0% CH3CN was apparent. This peak
had a shoulder which eluted at 75.9% CH3CN.
Since other work by Rathbone and his co-workers (Rathbone et al.,
1992a) had revealed that AMP could be isolated from the 18 day chick
embryo brain and that it was a mitogen for chick brain non-neuronal cells,
5'-AMP was also eluted under identical conditions as those utilized to
separate rp-HPLC fraction #7. A typical elution profile of 5'-AMP is shown
in Figure 23b. A sharp symmetrical peak initiated elution at 11.0 minutes
or 55.0% CH3CN. Like 5'-GMP, Sf-AMP eluted much later than rp-HPLC
fraction #7.
c. Proton nuclear magnetic resonance spectroscopy (lH-NMR)
of rp-HPLC fraction #7
In order to gain some information regarding the molecular structure
of the material comprising rp-HPLC fraction #7, the lyophilized sample was
reconstituted in D20 and a IH-NMR spectrum was run. Unfortunately, no
signal was seen due to the inadequate sample size. Approximately 1 mg of
pure sample is required to detect a 1H-NMR signal. In large molecules
such as peptides and proteins, a larger sample is necessary since the
molarity of individual protons is low.
D. Biological activity of the nucleotides
GMP, cGMP, AMP, and cAMP
The purification employed by Kim et ale (1991) resulted in the
identification of a mitogenic fraction from chick embryo brains as GMP;
Figure 23. RP-HPLC Elution Profiles of 5'-GMP and 5'-AMP.
A J,!Bondapak Cl 8 column was used to individually
chromatograph commercially available 5'-GMP and 5'_
AMP under identical conditions as those employed in the
isolation of rp-HPLC fraction #7, namely a gradient of
0.1 % to 99.9% CH3CN in H20 with 0.05% TFA in 20
minutes. The elution profiles were monitored at 280 nm.
(5'-GMP = guanosine 5'-monophosphate; 5'-AMP =
adenosine 5'-monophosphate; RP-HPLC = reversed phase
high-performance liquid chromatography; TFA =
trifluoroacetic acid)
A: Rp-hplc elution profile of 5'-GMP.
B: Rp-hplc elution profile of 5'-AMP.
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the isolated material was biologically active on the chick brain non-
neuronal cells at 50 11M. These researchers used the same protocol to
isolate AMP from the chick embryo brain; it maximally stimulated chicl(
astrocyte growth at 500 nM (Rathbone et aI., 1992a). The research project
outlined in this thesis endeavoured to determine the biological activity of
commercially available 5f-GMP and Sf-AMP, as well as a number of other
nucleotides. The chick embryo brain non-neuronal cell bioassay was used
as it had been throughout this work.
Commercially available 5f-GMP was tested for its biological activity
on the non-neuronal cells. Two 24 well plates were assayed, each with
three concentrations of GMP; the results are depicted in Figure 24a and b.
From Figure 24a, it is apparent that at 50 11M, GMP was inhibitory to cell
proliferation and caused a significant 29.0% decrease in 3H-thymidine
incorporation. The inhibition of cell growth seen at GMP concentrations of
500 11M and 5 11M were not statistically significant. The control 10% FBS
was significantly stimulatory affecting a 94.2 % increase in cell growth. The
results of Figure 24b indicate that low concentrations of GMP were also
inhibitory to 3H-thymidine incorporation in the test cells. At 0.5 11M, GMP
produced a significant 24.8% decline in non-neuronal cell growth when
compared to treatment with the 1% FBS control. A concentration of
0.05 11M GMP also caused a significant decrease in cell proliferation of
23.1 %. Similarly, 0.005 11M GMP significantly inhibited cell growth by
14.7%. Cell proliferation was significantly increased 58.1% by 10% FBS in
this assay.
Cyclic GMP (cGMP) was also tested in the non-neuronal bioassay
(Figure 25). At the highest concentration examined, 5450 nM cGMP was
inhibitory to cell growth and caused a significant 46.1 % decrease in
3H-thymidine incorporation in the test cells. No effect on the cells was
registered when cGMP was assayed at 545 nM. However, at 5.45 nm,
cGMP was most biologically active and affected a statistically significant
Figure 24. Effect of 5'-GMP on 3H-thymidine Incorporation in
Cultured Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the 5'-GMP concentrations tested and
the 10% FBS control. Statistically significant differences
(p~0.05) are represented by an "x tt over the
corresponding bar on the graph. n = 5 for each 5'-GMP
test concentration and the 1% FBS control; n = 4 for the
10% FBS control. Second subculture cells were used.
(5'-GMP = guanosine 5'-monophosphate; FBS = fetal
bovine serum)
A: 5'-GMP concentrations tested: 500 JlM, 50 11M, and
5 JlM.
B: 5'-GMP concentrations tested: 0.5 JlM, 0.05 JIM,
0.005 JlM.
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Figure 25. Effect of cGMP on 3H-thymidine Incorporation in Cultured
Chick Embryo Brain Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the cGMP concentrations tested and
the 10% FBS control. Statistically significant differences
(psO.05) are represented by an "x" over the
corresponding bar on the graph. n = 4 for each cGMP test
concentration and the 1% and 10% FBS controls. Second
subculture cells were used. (cGMP = cyclic guanosine
monophosphate; FBS = fetal bovine serum)
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35.4% increase in 3H-thymidine uptal(e. At 0.545 nm, this nucleotide also
significantly stimulated a 21.1 % increase in cell growth. As is evident, the
biological effects of cGMP manifest themselves in a dose-dependent
fashion. In this assay, treatment with 10% FBS resulted in a significant
133.6% rise is radio-label uptake.
When AMP was assayed, it was found to have no effect on non-
neuronal cell growth (Figure 26a). It was tested at 50 11M, 5 JlM, 0.5 11M,
and 0.005 11M, but it caused no statistically significant change in
3H-thymidine incorporation in the cells when compared to the 1% FBS
control. However, 10% FBS produced a significant 209.8% stimulation of
cell growth.
Treatment with cyclic AMP (cAMP) also caused no change to the
3H-thymidine uptake of the non-neuronal cells. There was no statistically
significant effect on cell growth when cAMP was tested at 50 JlM, 5 11M,
0.5 11M, and 0.05 JlM. On the other hand, 10% FBS affected a significant
127.8% increase in 3H-thymidine incorporation in these cells. These results
may be seen in Figure 26b.
E. Effect of pronase treatment on the
biological activity of P6-3
Another method which was used to contribute information to the
characterization of CBGF was pronase treatment of the biologically active
material; the sample subjected to this non-specific proteolytic digestion
was then tested for activity in the non-neuronal cell bioassay. With such a
test, one would expect to observe a decrease in biological activity if the
mitogen in question were of a peptide or protein nature. If the mitogen
were some other type of molecule, one would anticipate that pronase
treatment would have no effect on biological activity.
Figure 26. Effect of Sf-AMP and cAMP on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Data are presented as percent difference from the 1% FBS
control for each of the nucleotide concentrations tested
and the 10% FBS control. Statistically significant
differences (pg).05) are represented by an "x ff over the
corresponding bar on the graph. n == 4 for each 51-AMP
and cAMP test concentration and the 1% and 10% FBS
controls. (Sf-AMP = adenosine 5'-monophosphate;
cAMP = cyclic adenosine monophosphate; FBS = fetal
bovine serum)
A: Results are given for Sf-AMP. Second subculture cells
were used.
B: Results are given for cAMP. Third subculture cells
were used.
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The active fraction P6-3 was incubated with pronase and the
resultant mixture was used in the bioassay. In addition to 1% and 10%
FBS, two other controls were included in this assay. The first was an
incubation of distilled H20 with pronase, employed in the test procedure to
determine the effects of pronase alone on chick brain non-neuronal cell
growth. The second control involved the treatment of cells with
undigested P6-3, which would stimulate cell proliferation. In this way, it
was possible to compare the effects of the pronase treated mitogen with
the unaltered factor while taking into consideration the extraneous effects
of the pronase itself. The results of this assay are presented in Figure 27.
The pronase alone (pro. con.) had no statistically significant effect on cell
growth. As previously noted, fraction P6-3 at 30 ng/ml caused a
significant 64.3% increase in 3H-thymidine incorporation in the non-
neuronal cells. Surprisingly, P6-3 treated with pronase produced a
statistically significant 123.0% stimulation of 3H-thymidine uptake in the
cells. Not only was this increase significantly greater than 1% FBS, but
more importantly it represented stimulation over levels achieved with
both pronase and the active fraction P6-3 alone. These findings were
confirmed using the P6-3 fraction isolated from a different preparation.
The amount of P6-3 used for pronase digestion corresponded to a final
concentration of 30 ng/ml when administered to the non-neuronal cells.
The 10% FBS control promoted a significant 175.7% increase in
3H-thymidine uptake in the test cells.
In order to determine whether the stimulation of cell growth
achieved with pronase treated P6-3 was due to an increase in the
extracellular amino acid pool, a control assay was performed. Bovine
serum albumin (BSA) was incubated with pronase under the conditions
employed in the pronase treated P6-3 assay. A pronase control in which
pronase and distilled H20 were incubated together was also included to
ascertain any effects the pronase might have on cell growth. Untreated
Figure 27. Effect of Pronase Treated P6-3 on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain Non-
neuronal Cells.
P6-3 was incubated with pronase and tested at a P6-3
concentration of 30 ng/ml (P6-3 + pro.); controls of
distilled H20 incubated with pronase (pro. con.) and
untreated P6-3 at 30 ng/ml (P6-3 30 ng/ml) were also
tested. Data are presented as percent difference from the
1% FBS control for each of the treatments tested and the
10% FBS control. n = 4 for the 1% and 10% FBS controls
and the pronase control; n = 6 for the untreated P6-3
and the pronase treated P6-3. Second subculture cells
were used. (FBS = fetal bovine serum)
Statistically significant differences (p~0.05) are
represented by the following symbols over the
corresponding bar on the graph:
x = significantly different from 1% FBS control;
o = significantly different from pronase control;
* = significantly different from untreated P6-3 at
30 ng/ml.
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BSA at 1 Jlg/ml was also tested to determine the effects of this protein
alone on cell proliferation. The findings of this control assay are given in
Figure 28. In this assay, pronase alone caused a statistically significant
43.6% decrease in 3H-thymidine uptake in the non-neuronal cells. BSA
alone was also inhibitory to cell proliferation affecting a significant 42.0%
decrease. Pronase digested BSA also caused a decrease in 3H-thymidine
incorporation of 30.5% in the cells; this decline was to a lesser extent than
caused by BSA alone. In fact, this represented a statistically significant net
increase in cell growth compared to the level accomplished by BSA alone.
For those cells tested with pronase treated BSA, the final concentration of
BSA applied to the cells was 1 Jlg/ml. In contrast, 10% FBS significantly
stimulated a 93.6% increase in 3H-thymidine incorporation in these cells.
F. Fast atom bombardment mass spectrometry
of rp-HPLC fraction #7 and various other molecules
Fast atom bombardment mass spectrometry (FAB-MS) was a
technique employed to ascertain the molecular weight and other
characteristics of the chemical composition of rp-HPLC fraction #7. Since
previous worl( had indicated that the active fraction isolated from the
chick embryo brains was a peptide of an estimated molecular weight of
1,500 Da. (Carlone" et al., 1987), the system was initially tested with a
peptide of similar molecular weight. Bombesin, at 1,619.8 Da, was chosen
for this purpose; its amino acid sequence has been shown to be pGlu-Gln-
Arg-Leu-Gly-Asn-Gln-Trp-Ala- Val-Gly-His-Leu-Met-NH2 (Woll and
Rozengurt, 1989). Bombesin was dissolved in either 5% aqueous glycerol
(for flow probe) or glycerol alone (for mega probe). It did not readily go
into solution, but instead formed a milky white liquid. The bombesin
sample was introduced into the instrument in two ways: using a flow
probe and on the surface of a mega probe. Positive-ion spectra were
Figure 28. Effect of Pronase Treated BSA on 3H-thymidine
Incorporation in Cultured Chick Embryo Brain Non-
neuronal Cells.
BSA was incubated with pronase and tested at a P6-3
concentration of 1 Ilg/ml (BSA + pro.); controls of distilled
H20 incubated with pronase (pro. con.) and untreated BSA
at 1 Ilg/ml (BSA IJ,1g/ml) were also tested. Data are
presented as percent difference from the 1. % FBS control
for each of the treatments tested and the 10% FBS control.
n = 4 for the 1% and 10% FBS controls and the pronase
control; n = 6 for the untreated BSA and the pronase
treated BSA. Second subculture cells were used. (BSA =
bovine serum albumin; FBS = fetal bovine serum)
Statistically significant differences (pg).05) are
represented by the following symbols over the
corresponding bar on the graph:
x = significantly different from 1% FBS control;
* = significantly different from untreated BSA at 1 Ilg/ml.
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collected. The first inlet system was successful in yielding a pseudo-
molecular ion at m/z 1,621 (bombesin + H+), but little amino acid sequence
information. However, sample introduction via the mega probe not only
produced the pseudo-molecular ion at m/z 1,621, but also useful sequence
data (Figure 29). Amino acid sequence specific information may be
obtained using FAB-MS by virtue of the fact that fragmentation generally
occurs at the peptide bond of peptides and proteins. A peak at the
appropriate fragment ion molecular weight thus appears in the spectrum.
Beginning at the pseudo-molecular ion, it was possible to determine the
first six amino acid segment of bombesin from the carboxy-terminus
(pGlu-Gln-Arg-Leu-Gly-Asn-). In this manner, it was also possible to
elucidate the final seven amino acid portion of the peptide from the
amino-terminus (Met-Leu-His-Gly-Val-Ala-Trp-). Charting the
fragmentation of these sequence specific sections of bombesin was
facilitated by the prior knowledge of this peptide's amino acid sequence.
In contrast, the FABMS of rp-HPLC fraction #7 was not so
straightforward. Like bombesin, this mitogen was reconstituted in 5%
aqueous glycerol (for flow probe) or glycerol alone (for mega probe).
However, this substance readily dissolved to yield a clear, colourless liquid.
The sample rp-HPLC fraction #7 was also introduced into the mass
spectrometer via both the flow probe and the mega probe. The flow probe
was used in two attempts to acquire a mass spectrum. Positive ion spectra
were collected. Fragmentation of the sample occurred, but no clearly
identifiable molecular ion or fragmentation pattern resulted. The largest
ions apparent were at m/z 1522 in the first spectrum and at m/z 1248 in
the second spectrum. Work with the mega probe also did not reveal a
definitive molecular ion. From Figure 30, it is evident that the ion of
largest molecular weight is at m/z 1610. Fragmentation patterns are not
readily distinguishable and amino acid sequence ions (should CBGF be a
peptide) are not clearly visible as they were for bombesin. Three
Figure 29. Positive-ion FAB Mass Spectrum of Bombesin.
The sample was dissolved in glycerol and introduced via
a mega probe. Amino acid fragmentation from both the
carboxy-terminus and amino-terminus of the peptide are
indicated.
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particularly abundant ions are present at low molecular weight. At
m/z 223, an ion of two glycerol molecules with a potassium atom can be
seen. The ion at m/z 337 is representative of a glycerol trimer with
associated potassium and sodium atoms. The identity of the ion at
m/z 481 was deduced to be three glycerol molecules with five
accompanying sodium atoms and one phosphate (P04) group. The sample
had been dissolved in a glycerol matrix. Glycerol forms aggregates and the
glycerol spectrum is often visible when the spectrum of the sample of
interest is weak. In the purification of rp-HPLC fraction #7 various buffers
were used. Some of the metal ions of these salts have evidently associated
with the sample and with its glycerol matrix. Ions with these associated
metal atoms do not appear in the FAB mass spectrum of glycerol alone.
The three ions at m/z 223, 337, and 481 were also present in the mass
spectra of rp-HPLC fractions #10 and #11, much later eluting fractions
than rp-HPLC fraction #7. This would indicate that these ions are matrix-
related, supporting the aforementioned identifications.
Since rp-HPLC fraction #7 behaved differently than the bombesin
sample under identical FAB-MS conditions and since other researchers had
isolated both GMP and AMP from the 18-day chick embryo brain (Kim e t
al., 1991; Rathbone et al., 1992a), the positive-ion FAB mass spectra of a
variety of nucleotides and other molecules were determined. The
following molecules were analyzed by FAB-MS: 5'-GMP, cGMP, 5'GDP,
51-GTP, ddGTP (2,3-deoxy GTP), 51-AMP, cAMP, 51-ADP, 51-ATP, ddATP,
5'-TMP, ddTTP, ddCTP, glucose, sorbitol, and starch. None of these samples
dissolved as readily in glycerol as rp-HPLC fraction #7. Moreover, the
mass spectra did not share similar features with the rp-HPLC fraction #7
mass spectrum. Each nucleotide displayed a strong pseudo-molecular ion
at an m/z value of the molecular weight + 1; no abundant ions at any of
these m/z values were evident in the mass spectrum of rp-HPLC fraction
#7.
DISCUSSION AND CONCLUSIONS
Optimization of Cell Culture and Bioassay Conditions
This research has established the basic growth requirements of
cultured non-neuronal cells from the lO-day chick embryo brain. In
addition, the three bioassay parameters, duration of quiescence,
stimulation, and 3H-thymidine labeling, were determined for these
non-neuronal cells in vitro. A preliminary attempt to define the cell
culture composition was also undertaken.
The non-neuronal cells employed in this study grew best on plastic
tissue culture dishes coated with the extracellular matrix component
collagen as opposed to uncoated dishes. The cells proliferated rapidly on
this substrate, with primary cultures reaching confluence after
approximately three days; while some other research groups do not use
collagen-coated dishes when culturing astroglial cells, their cultures grow
more slowly, not reaching confluence until 7 to 12 days (Courtin et al.,
1990; Huff and Schreier, 1990; Jensen and Chiu, 1991).
The ability of non-neuronal cells to respond to a proliferative
stimulus (10% FBS) was found to be dependent on the number of
subcultures the cells had undergone. Thus, second subculture cells were
determined to be more responsive than first subculture cells. While no
statistical difference was detected between second and third subculture
cells, the older cells demonstrated a general decrease in responsiveness.
Since only those assays in which a significant difference in 3H-thymidine
incorporation between treatment with 1% and 10% FBS were utilized, an
insufficient number of fourth subculture cells remained to be compared to
third subculture cells; none the less, this in itself was an indication that
these older cells were less responsive to 10% FBS than their second and
third subculture counterparts from the same cell preparation. Other
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studies have shown that, during serial subcultivation, the percentage of
cells participating in DNA synthesis decreases, the average cell cycle time
increases, primarily as a result of an increase in 01, and that, consequently,
senescent cells are thought to be blocked in late 01 or at the OtIS border
(Cristofalo et al., 1989). Rathbone et ale (1992c) demonstrated that the rate
of proliferation of cultured primary cells decreased as they aged in vitro,
with chick brain astrocytes exhibiting this decline earlier than meningeal
fibroblasts or human endothelial cells. Furthermore, as the number of
serial subcultivations increases, the sensitivity of cells to growth factors
diminishes; this was observed for chick brain astrocytes, meningeal
fibroblasts, and human endothelial cells in response to purine
nucleosides/nucleotides (Rathbone et aI., 1992,c) and for rat Schwann cells
in response to glial growth factor (Goodearl et al., 1993). Late passage
fibroblast cells have been thought to resist mitogenic stimulation in part
because of their increased production of prostaglandin E2 to levels that
inhibit growth in young cells (Cristofalo et al., 1989). In addition, the
number of growth factor receptors may decline for aged cells as is the case
for high affinity epidermal growth factor receptors on cultured fibroblasts
(Kawamoto et al., 1989). The conclusions of the present study indicate that
the chick non-neuronal cells are most responsive to growth factor
stimulation and most effective in a bioassay when used at the second
(preferably) or third subculture.
When a comparison of 3H-thymidine incorporation in non-neuronal
cells grown in incomplete medium containing only a-MEM, FBS, glucose
and antibiotic/antimycotic and those grown in complete medium
containing the aforementioned ingredients as well as the additives insulin,
sodium selenate, transferrin, putrescine and progesterone was made, it
was found that complete medium was more effective; thus, complete
medium was employed throughout this work. The added components of
the complete medium were also individ.ually supplemented to 0.1 % FBS in
incomplete medium, demonstrating that 3x10- 8 M sodium selenate and
5 Ilg/ml insulin increased DNA synthesis, while 2x10- 8 M progesterone
decreased it. Since the results of the individual components were only
compared to 0.1 % FBS and 10% FBS in incomplete medium on the same
culture plate, it would also be informative to compare these findings to
0.1 % FBS in complete medium in a future study. The present results
indicate that the medium supplements are more effective when used in
conjunction with each other than when employed individually; the
contribution to cell stimulation by each could be additive or synergistic.
The use of supraphysiological levels of insulin in this study and others
supports the view that insulin's effects are mediated by the insulin-like
growth factor-1 (IGF-1) receptor (Baskin et aI., 1988; Toran-Allerand e t
al., 1991).
Despite the fact that other studies have employed a serum-free
medium with which to render their astroglial cells "quiescent" (Carlone e t
al., 1987; Kim et a/., 1991), this research has ascertained that non-
neuronal cells treated with either 0% or 0.1 % FBS appeared less healthy
arId experiellced iflcreased cell death thatl cells ill tlle presellce of eitller
:1 % or :10% F,BS. T11us, everl thouglluse of 0.1 % FBS Illore effectively rneets
the goal of quiescence, that is, to maximize the difference between cell
growth in the "quiescent" state and in 10% FBS, use of 1% FBS was deemed
more suitable in light of its positive effect on non-neuronal cell health.
The conditions of the growth factor bioassay on the chick non-
neuronal cells had not been previously optimized. The first parameter
examined was the duration of "quiescence". Since the cell culture medium
contained 1% FBS for this step in the bioassay, the cells were actually at a
basal level of growth rather than truly quiescent and not dividing; none
the less, the goal of maximizing the difference between the cells' response
to 10% and 1% FBS was achieved. Incorporation of 3H-thymidine
decreased over the period from 3 to 14.5 hours of "quiescence". Th.is
154
155
represented a diminishing residual response to growth in 10% FBS, likely
due to an average decreasing rate in progression through the cell cycle.
After 14.5 hours, a constant basal level of growth was maintained until at
least 72 hours "quiescence"; during this time, the cells were no longer
reacting to the residual effects of growth in 10% FBS, but were responding
to growth in 1% FBS with a stabilized, constant rate of movement through
the cell cycle. Thus, it was during this period that the difference between
growth in 10% and 1% FBS had reached a maximum. Twenty-four hours
"quiescence" was chosen as a convenient time which fell within this range,
and was employed in all subsequent bioassays.
The second bioassay constraint to be examined was the length of cell
growth stimulation prior to the addition of a radioactive label. In the
presence of 10% FBS, the non-neuronal cells had an increasing rate of
3H-thymidine incorporation which reached a maximum at 6 hours of
"prestimulation"; this was followed by an initial rapid and then slow
decline in label uptake. Thus, the optimum duration of "prestimulation"
was 6 hours, or a total of 30 hours of growth stimulation, 24 hours of
which included a radioactive label. This lag in response to a growth
stimulus, such as 10% FBS, has been attributed in other studies to be a
result of residual effects from the lengthy "quiescence" period which
precedes the stimulation phase (Huff and Schreier, 1990). As a
comparison, treatment of rat astrocytes with either bFGF or EGF caused an
increase in 3H-thymidine incorporation which maximized after 18 to 24
hours (Huff and Schreier, 1990).
Other researchers have reported the time required for cells in
culture to first demonstrate a response to a growth stimulus following
quiescence. Kim et ale (1991) determined that chick astrocytes needed less
than 8 hours in the presence of GMP before an increase in 3H - thy mid i n e
incorporation was registered. The human fibroblast cell line Wl-38
entered DNA synthesis 12 hours after the addition of EGF, IGF-l and
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dexamethasone (Cristofalo et al., 1989); DNA synthesis in Syrian hamster
embryo cells was induced 10 to 20 hours following stimulation by 10% FBS
(Futreal and Barrett, 1991). The onset of DNA synthesis could be
determined for the chick non-neuronal cell system employed in this study
by varying the 10% FBS stimulation time and using a small 3H-thymidine
labeling time. It is interesting to note the decline in DNA synthesis that
takes place once the 6 hour maximum of "prestimulation" has been
reached. This decrease could be due to the depletion of the growth
stimulus in the medium by proliferating cells, the accumulation of toxic
cellular metabolites, or a combination of the two. In any case, the
"prestimulation" time should not exceed 6 hours; the previously used 24
hour "prestimulation" time was too long since it fell in the range of
declining DNA synthesis.
The third aspect of the bioassay to be studied was the duration of
3H-thymidine labeling. The amount of radioactive label uptake by the
non-neuronal cells increased linearly in the presence of 10% FBS over a
3 to 48 hour labeling period. Due to this positive correlation between
3H-thymidine incorporation and time, 24 hours was selected as a
convenient duration for labeling and was used throughout this study.
Other researchers have reported a similar linear relationship in their
examination of 3H-thymidine incorporation by chicl\: embryo astrocytes In
the presence of either 10% FBS, chick embryo brain extracts, guanine
nucleotides, or adenosine nucleotides over an 8 to 30 hour labeling period
(Kim et al., 1991; Rathbone et al., 1992a).
Since the optimization of the duration of pre-label stimulation and
3H-thymidine labeling was accomplished using 10% FBS, the results
obtained may be specific for treatment with this particular growth
stimulus and may differ slightly for the brain extracts and nucleotides
tested in this study. Future experiments pinpointing the precise bioassay
parameters required by these non-neuronal cells when using chick brain
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mitogens could alleviate this uncertainty.
A preliminary characterization of the composition of 10 day chick
embryo non-neuronal brain cells indicated that primary 4 day
subconfluent cells consisted of 6.63% GFAP positive cells. Despite the fact
that this finding suggests that these cultures contain few astrocytes, the
cells displayed the distinctive cobblestone morphology attributed to
confluent glial precursors, particularly astroblasts (Sensenbrenner, 1977;
Carlone et al., 1988; Andersson et al., 1994). Previously, this laboratory
had observed that cultures of 10 day chicl( embryo brain cells with this
cobblestone morphology were >90% GFAP positive (Carlone et al., 1988);
however, these cultures, unlike the ones employed in this study, had been
passaged an unreported number of times and were confluent when they
were tested one week after plating. It is therefore possible that these two
situations characterize not distinct cell types, but rather different
subpopulations of one cell type, tested under unique conditions. In fact,
astrocyte heterogeneity has been shown in type I astrocytes isolated from
anatomically distinct regions of the eNS (Wilkin et al., 1990; Landis, 1994).
Furthermore, marl(ed differences in GFAP levels have been observed in
astrocytes cultured from different regions of the brain (Wilkin et al.,
1990).
It is the differing conditions under which these cells were tested
which may have caused different subpopulations of the same non-
neuronal cell type to arise. One of the factors to be considered is the age of
the cell culture. Similar to the research on chick embryo astrocytes
(Carlone et al., 1988), neo- and post-natal rat astrocytes have been
observed to be 95% GFAP positive (Huff and Schreier, 1990; Jensen and
Chiu, 1991); however, both of these instances represent much older
cultures which remained as primary cultures for up to 10 days and were
subsequently subcultured prior to GFAP testing. Kim et ale (1991) also
reported that their older chick astrocyte cultures were over 90% GFAP
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positive, but that earl y astroblast cultures contained a majority of cells
that had not yet become GFAP positive. This result agrees with other
investigations showing that astroblasts (astrocyte precursors) do not stain
for GFAP (Pixley et 'ai., 1984). This may suggest that the cultures of this
study were young, consisting primarily of astroblasts. Andersson et ale
(1994) observed that the density of glial filaments in type 1 rat astrocytes
dramatically increased with increasing days in vitro. While the
morphology of the astrocytes in the present study appeared to be that of
type 1 astrocytes, this trend has also been observed in type 2 astrocytes:
immature type 2 astrocytes in vitro express low levels of GFAP, however
once they mature OFAP expression increases (Lillien and Raff, 1990).
Another aspect of cell culture conditions that has been shown to play
a role in GFAP expression is the cell density (Toran-Allerand et al., 1991).
Unlike the aforementioned 90% GFAP positive confluent astrocyte cultures
of Carlone et ale (1988), those employed in the present work were
subconfluent. Goldman and Chiu (1984) have shown that while the
majority of neonatal rat astrocytes in their studies were GFAP positive
regardless of the cell density, low density cells possessed a dimmer
fluorescence intensity than high density cells. A general faint level of
fluorescence, above those of control assays, was observed in non-neuronal
cells tested in the present study; however only those cells displaying an
obviously high degree of fluorescence were counted as GFAP positive cells.
This possibly erroneous result could be clarified either by allowing the
cells to reach confluence or by treating low density cells with colchicine to
induce coiling of intermediate filament bundles, thereby making
immunofluorescent staining easily visible (Goldman and Chiu, 1984). It
has also been shown that low density astrocytes actually contain and
synthesize less GFAP than high density astrocytes (Goldman and Chiu,
1984).
The biochemical environment of astroglial cells also influences the
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level of GFAP expression. For example, acidic and basic FGF have been
demonstrated to change the distribution of GFAP when supplied to
astoglial cells in vitro (Weibel et al., 1985). The non-neuronal cells of this
study were cultured in the presence of a variety of growth promoting
substances including 5 llg/ml insulin. Other researchers have found that
few polygonal nonprocess-bearing glial cells were stained by GFAP in
organotypic cultures of embryonic mouse cerebellar astroglia exposed to
similarly high insulin levels (10 Ilg/ml) (Toran-Allerand et al., 1991).
Moreover, the concentration of progesterone used in the culture medium of
the current study was tOO-fold lower than that employed by Carlone et ale
(1988); although the published concentration of progesterone utilized by
Carlone et ale (1988) was the same used in this study (2x10-S M), the actual
concentration used by these researchers was 2xl0-6 M. This difference in
the culture media of these two studies may be sufficiently great to alter
the degree of OFAP expression.
Isolation and Purification of Chick Brain Growth Factor
This research has expanded and improved the isolation and
purification scheme for chick brain growth factor first outlined by Carlone
and his colleagues (Carlone and Rathbone, 1985; Carlone et al., 1987). In
the current study, CBGF was partially purified by ultracentrifugation,
ultrafiltration through Amicon PM-30 and YM-2 membranes (nominal
molecular weight cut-offs of 30,000 Da. and 2,000 Da., respectively), size
exclusion chromatography through a Biogel P6 column, and CIS rp-HPLC.
While a number of biological activities were present in the rp-HPLC
fractions, the most potent mitogen for cultured non-neuronal cells from the
10 day chick embryo brain resided in a fraction (rp-HPLC fraction #7)
found to be as effective as 10% FBS at stimulating 3H-thymidine
incorporation into these cells when tested at 10 ng/ml. This fraction
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represented a 943 fold purification of the active material over that of the
crudely purified PM-30 filtrate. The CBGF isolated in this work had a high
specific mitogenic activity in the non-neuronal cell bioassay, causing a
half-maximal stimulation of 3H-thymidine (EDs 0) into these cells at a
concentration of 5.3 ng/ml. This value is comparable to the one previously
reported for CBGF (EDs 0 = 5 ng/ml; 3 nM), purified to apparent
homogeneity using a slightly different protocol, but also to the level of Cl 8
rp-HPLC (Carlone et aI., 1987). The fact that CBGF is active at a
physiologically relevant concentration is evidenced by the comparable EDso
values exhibited by other growth factors and neuropeptides such as PDGF
(1 ng/ml; Raines and Ross, 1985), aFGF (-40 pg/ml; Thomas et al., 1984),
vasopressin (1 ng/ml; Rozengurt et al., 1979), and bombesin (1 nM;
Rozengurt and Sinnet-Smith, 1983).
The CBGF partially purified in this research was observed to be as
biologically active as 10% FBS when tested on chick embryo non-neuronal
cells in vitro; this was also the finding reported by Carlone et ale (1987)
for their homogeneous preparation. CBGF appears to be a particularly
potent mitogen. By comparison, EGF stimulates only one half and bFGF
merely one sixth as much 3H-thymidine incorporation in cultured rat
astrocytes as 10% FBS (Huff and Schreier, 1990).
The chick embryo brain non-neuronal cells exhibited a bell-shaped
concentration dependence for the CBGF isolated in the current study, much
like that observed previously by Carlone and Rathbone (1985). Such a
bell-shaped concentration dependence was also reported by Choo et ale
(1978; 1981) when these researchers examined the stimulation of protein
synthesis in cultured blastema explants from the regenerating amphibian
limb treated with a factor isolated from chick brains. Furthermore, both
the CBGF isolated in this research and the factor isolated by Choo et ale
(1978) are biologically active over a relatively natrow concentration range:
CBGF, between 1 ng/ml and 100 ng/m!, and Choo's factor, between
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0.5 rng/rnl and 1.5 mg/ml. The findings of Choo and his colleagues suggest
that their factor was a potential candidate for the trophic factor(s)
involved in blastema cell proliferation during the nerve-dependent limb
regeneration of Urodele amphibians. CBGF (10 ng/ml) has also been found
to be mitogenic for cultured forelimb blastemas from the adult newt,
Notophthalmus viridescens, causing an average 3.6-fold increase in the
percentage of 3H-thymidine-Iabelled blastema nuclei when compared to
control values (Carlone et al., 1987). Moreover, like the factors isolated
from nerve tissue in previous attempts to purify the trophic factor
involved in limb regeneration (Singer et al., 1976; Choo et al., 1981), CBGF
activity lacks species specificity since a similar preparation from adult
newt brain is also mitogenic for cultured blastemas (Carlone and Rathbone,
1985). Therefore, these findings point to a possible role for newt CBGF in
the nerve-dependent stimulation of blastema cell proliferation during
amphibian limb regeneration.
The CBGF isolation procedure, as previously described (Carlone and
Rathbone, 1985; Carlone et ai., 1987), involved the ultrafiltration of
18-day chick embryo brain homogenates through a series of Amicon filters
of decreasing porosity. The retentate of the final filter in this sequence,
the UM-05 membrane (nominal molecular weight cut-off of 500 Da.),
contained the biologically active fraction. However, this membrane, made
of a blend of polyelectrolytes, is no longer manufactured; the replacement
membrane, YC-05, is made of cellulose and has a nominal molecular weight
cut-off of 300-400 Da. Prior to this study, it was found that the YC-05
membrane did not retain the active fraction. Since the estimated
molecular weight of CBGF (1,500-2,000 Da.) was greater than the molecular
weight cut-off of the YC-05 filter, making it unlikely that CBGF would pass
through the membrane, it was speculated that the active fraction was
irreversibly bound to the new membrane. As a result, the filtrate collected
in the purification step preceding the use of the UM-05 membrane was
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applied to a Biogel P6 size exclusion column (with a molecular weight cut-
off of 6,000 Da.) from which a biologically active fraction was collected.
Use of a DEAE anion exchange column, as described by Carlone et ale
(1987), had been discontinued in a previous study (Seifried, honours
thesis, 1988). Purification of the active material proceeded with rp-HPLC
(Carlone et al., 1987). Since, several biological activities have been
identified in this system (Carlone et al., 1987), the changes to the isolation
and purification protocol described in this study may have resulted in the
isolation of a mitogen different from CBGF.
Variations in the non-neuronal cells' response to 10% FBS were seen
throughout the course of this study. A factor in these variations, namely
the number of subcultures which the cells have undergone, has already
been discussed. However, differences in cell responsiveness were
observed even in cells from the same subculture; this observation has also
been noted by other researchers working with cultured chick embryo
astrocytes (Rathbone et al., 1992b). Throughout the course of this
research, all test wells were seeded at the same density. However, the
length of time from the seeding of a plate to the onset of a bioassay varied
slightly from plate to plate. Thus, although the individual wells of any
given culture plate all had equivalent numbers of cells at the start of each
bioassay, the density of cells from one plate to another was different. For
this reason, it was necessary to include control wells containing 1% FBS and
10% FBS in each bioassay plate and to express all data as the percent
difference from 1% PBS.
The difference in cell number in each bioassay plate is one factor
which can account for the apparent variation in cell responsiveness. Less
EGF stimulation has been found to occur in high versus low density
cultures of the human glial cell line (Westermark, 1976); furthermore,
bFGF potency has also been observed to be negatively correlated with
plating density when tested on cultures of CNS neurons (Knusel et al.,
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1989). Since the non-neuronal cells of the current study grow in a
monolayer, one might argue that growth stimulated high density cultures
would be prevented from further growth once the cells are confluent,
thereby explaining the results reported by Westermark (1976) and Knusel
et ale (1989). However, this supposition does not affect the validity of the
results obtained for cells tested with a test fraction, since 10% FBS
stimulated 3H-thymidine incorporation into the cells to a greater degree.
Moreover, the situation is more complex than a simple contact inhibition
effect, as evidenced by the fact that researchers have found the number of
surface bFGF receptors to decrease with increasing cell density in a
nontransformed cell line (Veomett et al., 1989). It has also been suggested
that in high density cultures added factors, like bFGF, are more rapidly
removed from the medium by a variety of mechanisms, such as specific
and nonspecific binding, causing the effective factor concentration in the
medium to quickly decline (Knusel et al., 1990). Other studies contrast
with these, finding greater EGF stimulation in high density neonatal rat
astrocyte cultures; the authors attributed these results to a possible
starvation effect for EGF in more confluent cultures or a synergistic effect
from a different unknown factor produced in greater quantities at higher
cell densities (Huff and Schreier, 1990). Each of these examples points to a
variable response to the same factor by lower and higher density cultures.
Characterization of CBGF' s Biochemical Characteristics
UV absorbance spectra, rp-HPLC profiles, and mass spectra
comparing rp-HPLC fraction #7 and commercially available 5'-GMP have
all clearly shown that the partially purified CBGF found in rp-HPLC fraction
#7 is not 5'-GMP. Moreover, 5'-GMP was tested in the non-neuronal cell
bioassay over the concentration range 0.005 - 500 11M and, unlike rp-HPLC
fraction #7, was not found to be biologically active.
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The findings of the present study contrast with those reported by
Kim et ala (1991). These researchers have isolated the most active of
several fractions from the 18-day chick embryo brain and determined it to
be 51-GMP. They found that this fraction, as well as commercially available
5'-GMP, stimulated 3H-thymidine incorporation into cultured 10-day chick
embryo brain astrocytes in a dose-dependent fashion with a maximal
activity at 50 JlM (Kim et al., 1991). In contrast, the research presented in
this thesis has indicated that 50 11M 51-GMP is inhibitory to chick embryo
brain non-neuronal cell division.
The findings of Kim et ale (1991) do not preclude the fact that other
activities reside in the chick embryo brain; indeed, these researchers
noted the presence of 51-AMP in addition to other mitogenic fractions
(Rathbone et al., 1992a,b), but found the fraction identified as 5'-GMP to be
the most stimulatory to 3H-thymidine incorporation under their bioassay
conditions. Others have reported the existence of peptide growth factors in
the embryonic chick brain (Choo et al., 1978; Carlone et al., 1987). While
the results of the current study do not support the identification of
rp-HPLC fraction #7 as 5'-GMP, this nucleotide may be a component of the
crude chicl( embryo brain homogenate, albeit a biologically inactive one for
the chick non-neuronal cells. Previous NMR studies have suggested that
two CBGF rp-HPLC fractions, one inactive and the other inhibitory,
contained nucleosides/nucleotides (M. Seifried, honours thesis, 1988).
While the factor isolation method and bioassay conditions employed
in this research and by Kim et ale (1991) are similar, a number of
differences exist which may explain the contradictory results obtained.
The first of these differences is the use of the UM-05 replacement
membrane, the YC-05, by Kim et ale (1991); using this membrane, these
researchers were successful in obtaining an active fraction in the retentate.
Since no biologically active material could be isolated from the retentate in
studies preceding the current thesis research, a variation in the isolation
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procedure was adopted in which the YM-2 filtrate was directly applied to a
Biogel P6 size exclusion column. In the study by Kim et ala (1991), the
YC-05 retentate was applied to a DE-52 anion exchange column for further
purification; a similar step, previously employed by Carlone et ala (1987),
was eliminated in a prior study. This may suggest that these alternate
protocols result In the purification of different active fractions.
Moreover, in the bioassay conditions employed in this thesis study,
non-neuronal cells were rendered quiescent in medium supplemented
with 1% FBS for 24 hours prior to the addition of various test fractions.
However, Kim et ale (1991) rendered their ten-day chick embryo brain
astroblasts quiescent in medium containing 0% FBS for 72 hours. When the
ten-day chick embryo brain non-neuronal cells of the present study were
incubated with medium containing 0% FBS, many died while the remaining
cells appeared unhealthy; for this reason, medium supplemented with
0% FBS was deemed unsuitable for non-neuronal cell maintenance and 1%
FBS was used. Furthermore, in the current research it was found that the
optimal length of time for incubating the cells with the test factor prior to
the addition of 3H-thymidine was 6 hours. In contrast, Kim et ala (1991)
utilized a preincubation time of 24 hours; it is unknown whether this time
was optimized. These differences in the bioassay conditions may indicate
that either different cell types or subpopulations of the same cell type are
being selected for in these two studies.
Kim et ale (1991) reported that the cells which they used were GFAP
positive, and so identified them as astroblasts. On the surface, this fact
would seem to support the notion that the current research project and
that of Kim et al. (1991) dealt with different cell types, since young
primary (4 day) non-neuronal cells of the present study were determined
to be largely GFAP negative, and therefore could not be identified as
astroblasts/astrocytes. However, as previously mentioned, Kim et al.
(1991) conducted GFAP testing on older cells (7 days after subculturing),
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while cultures used for bioassay contained a majority of cells which had
not yet become OFAP positive. As discussed in a previous section, the non-
neuronal cells of this thesis work could simply be astroblasts which, like
the bioassay cells employed by Kim et ale (1991) have not yet become
GFAP positive. The differing results observed may then be attributable to
the presence of various subpopulations of astroblasts which arose from the
alternative bioassay conditions used.
While the data obtained in this thesis research indicates that the
partially purified CBOF found in rp-HPLC fraction #7 is not 51-GMP, the
identity of the active material is still to be determined. The UV
absorbance spectrum of rp-HPLC fraction #7 revealed a peak at 257.5 nrn,
but none at 280 nm suggesting the possibility of the presence of a
nucleoside/nucleotide in the sample (Scopes, 1982). This fact, in addition
to findings by other researchers showing that 51-AMP can be isolated from
the 18 day chick embryo brain, albeit as the least biologically active
fraction, and that it is mitogenic for chick embryo brain astrocytes
(Rathbone et al., 1992a), prompted an investigation of the characteristics of
commercially available 5 1-AMP under the conditions employed throughout
this study.
While 51-AMP and rp-HPLC fraction #7 share a UV absorbance
maximum at 257.7 nm, under identical rp-HPLC elution conditions Sf-AMP
elutes much later than rp-HPLC fraction #7; furthermore, their FAB mass
spectra are dissimilar. Moreover, when assessed in the chick embryo brain
non-neuronal cell bioassay, Sf-AMP had no statistically significant effect on
3H-thymidine incorporation in these cells at any of the concentrations
tested (50 11M,S 11M, 0.5 lJM, and 0.005 JlM).
The fact that 51-GMP and 51-AMP were found to elute later than
rp-HPLC fraction #7 under identical rp-HPLC elution conditions has
indicated that rp-HPLC fraction #7 does not contain these nucleotides. It is
unlikely that the retention time of these nucleotides would be altered if
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they were part of a mixture of molecules, such as the one represented by
rp-HPLC fraction #7 (J. Miller, personal communication). Other researchers
have isolated 5'-GMP from the 18 day chick embryo brain (Kim et al.,
1991); however, the elution time of this nucleotide (both purified from the
chick embryo brain and commercially obtained) was unchanged from its
elution time when a component of the partially purified mixture.
In addition to 5 f -GMP and Sf-AMP, cAMP and cGMP were also tested
in the non-neuronal cell bioassay and were examined by positive-ion FAB
mass spectrometry. While cGMP caused a statistically significant increase
in 3H-thymidine incorporation over control at 5.45 nM and 0.545 nM in
these cells, its pseudo-molecular ion (at an m/z value of the molecular
weight + 1) was absent from the mass spectrum of rp-HPLC fraction #7.
Therefore, the mitogenic activity of cGMP on the chick non-neuronal cells
is unrelated to that of rp-HPLC fraction #7. Indeed, cGMP has been
implicated as having a role in cell proliferation (Globus et al., 1987). cAMP
had no effect on the non-neuronal cells; its mass spectrometry data is
inconsistent with its identification as a component of rp-HPLC fraction #7.
The lack of a UV absorbance peak at 280 nm, a region typically used
to monitor the presence of peptides and proteins in a sample, does not
necessarily preclude identification of the active component of rp-HPLC
fraction #7 as a peptide/protein. The amino acids absorbing at this
wavelength are tyrosine and tryptophan; a small peptide, as CBGF
(approximately 1,500-2,000 Da.) appears to be as indicated by this study
and others (Carlone et al., 1987), might entirely lack these residues,
thereby in turn lacking the appropriate peak in its UV spectrum. Indeed,
preliminary amino acid analysis confirms that CBGF does not contain
tyrosine or tryptophan (Carlone et al., 1987). The existence of a UV
absorbance maximum in a region generally associated with absorption by
nucleic acids may indicate that rp-HPLC fraction #7 contains
nucleosides/nucleotides, albeit not 5'-GMP or 5 f -AMP. Although the
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biologically active material may be wholly or partially comprised of nucleic
acids, these molecules may merely represent a contaminant in the partially
purified rp-HPLC fraction #7 where the active component is a peptide.
Previous homogeneous preparations of CBGF also displayed UV absorbance
maxima at 260 nm, but not at 280 nm (Carlone, personal correspondence).
Alternatively, the CBGF peptide may contain the amino acid phenylalanine
which absorbs UV light at 257.5 nm (Greenstein and Winitz, 1961); this
possibility is, however, not supported by preliminary amino acid analysis
which shows that CBGF has no phenylalanine residues (0.3 residues/mole
observed), based on an estimated molecular weight of 1,500 Da. (Carlone e t
al., 1987).
Interestingly, when P6-3 was subjected to non-specific proteolytic
digestion using pronase, its activity in the chicl<: embryo brain non-
neuronal cell bioassay was greater than that of untreated P6-3. Pronase
alone caused a small increase in 3H-thymidine incorporation in the cells,
and while this was not a statistically significant difference from the 1% FBS
control, it presents the possibility that the increase in DNA synthesis
produced by the pronase treated P6-3 merely represents the additive
effects of pronase alone together with P6-3 alone. However, pronase
treated P6-3 elicited an additional 27.7% 3H-thymidine incorporation over
what would be expected from a simple additive effect. Moreover, in other
bioassays, the pronase control was seen to cause a slight decrease in
radiolabel uptake.
If pronase treatment indeed increases the activity of P6-3, the
question as to the identity of CBGF is further complicated. Previous studies
showed that trypsin affected a decrease in CBGF (UM-05 retentate fraction)
activity, indicating that this factor is a peptide (Carlone and Rathbone,
1985). The current pronase data raises a number of alternative
possibilities for the composition of CBGF. One of these possibilities is the
presence of a protein having an inhibitory effect on 3H-thymidine
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incorporation. This protein may be a component of the mixture of
molecules making up the P6-3 fraction or may be bound to the active
molecule. In light of the fact that higher concentrations of rp-HPLC
fraction #7, in addition to other rp-HPLC fractions, cause a decrease in
3H-thymidine uptake, the presence of an inhibitor is further supported.
Pronase digestion of this inhibitor would permit the full biological activity
to be realized. In order to reconcile this scenario with previous CBGF data
stating that the active component is a protein (Carlone and Rathbone, 1985;
Carlone et al., 1987) and with UV absorbance data, one might envision a
molecule consisting of a protein protected by a nucleoside/nucleotide
moiety. Either both components or only the protein constituent may be
required for biological activity. Alternatively, the activity isolated in this
thesis study may simply be chemically different from the CBGF purified in
the past (Carlone et al., 1987), and may solely consist of
nucleosides/nucleotides; however, it is clear that the mitogenic activity is
not caused by GMP or AMP.
The existence of biologically active molecules composed of
polypeptides complexed with polynucleotides has been previously
documented (Folkman etal., 1971; Wissler et al., 1988). Folkman et al
(1971) determined that a tumour cell-derived angiogenesis factor (TAF)
was composed of 25% RNA, 10% protein, and 50% carbohydrate, with the
remainder presumed to be lipoidal material. TAF activity could be
destroyed by digestion with ribonuclease, but remained unchanged
following exposure to trypsin; nonetheless, further studies implied that
the protein moiety associated with RNA in TAF was essential for the
factor's mitogenic activity (Folkman et al., 1971). Other researchers have
isolated a monocytic blood vessel morphogen for angiogenesis termed
monocyto-angiotropin (MAT) which was found to be comprised of
polypeptide, polynucleotide, and copper, calcium, sodium, and potassium
ion portions; the polynucleotide component contained two unidentified
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bases (Wissler et al., 1986; 1988). The polypeptide, polynucleotide, and
copper ion portions were all determined to be necessary for the expression
of full bioactivity. It is interesting to note that the UV absorbance
spectrum of MAT consists of a peak at approximately 260 nrn. Moreover,
the polypeptide component of MAT has proven to be inaccessible to amino
acid sequencing by Edman degradation (Wissler et al., 1986); this has also
been found to be the case for CBGF (R. Carlone, personal communication).
Moreover, the existence of biologically active RNA molecules has also
been proposed. Barakat et al (1984) isolated RNA as the active factor in
bovine brain extracts stimulating chicl, neuroblast proliferation in vitro;
they, however, suggest that the activity may actually be mediated by
nucleotides following RNA hydrolysis in the culture medium. On the other
hand, due to the fact that extracellular fluid contains numerous proteins
acting as either RNases or RNase inhibitors, researchers have hypothesized
that their substrate, intact extracellular RNA, likely has a role as a short
distance-short time intercellular messenger during the development of
higher organisms (Benner, 1988).
Not all bioactive molecules are represented by the usual spectrum of
biological compounds such as proteins and nucleotides; differentiation
inducing factor (DIF-l) from the slime mold Dictostelium discoideum is a
novel type of effector compound having the structure 1-(3,5-dichloro-2,6-
dihydroxy-4-methoxy-phenyl)-I-hexanone (Morris et al., 1987). Perhaps
CBGF is a similar non-traditional bio-effector.
FAB-MS was undertaken to gain size and structural information
about CBGF. While the FAB mass spectrum of rp-HPLC fraction #7 did not
display a definitive molecular ion, and thereby reveal the molecular
weight of CBGF, the ion of largest molecular weight was at m/z 1610. This
is consistent with previous FAB-MS data which suggested that the
molecular weight of CBGF is approximately 1600 Da. (R. Carlone, personal
communication). Although commercially available bombesin yielded a
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mass spectrum with a clear molecular ion and amino acid sequence
fragmentation, similar sequence information, be it caused by amino acids
or nucleotides, could not be gleaned from the rp-HPLC fraction #7 mass
spectrum. This may be due, in part, to the fact that rp-HPLC fraction #7
had not been purified to homogeneity due to the lack of an adequate
amount of this fraction. It is also possible that CBGF is a particularly
difficult molecule from which to obtain a mass spectrum.
Much of the difficulty in obtaining conclusive answers regarding the
structure of CBGF lies in the fact that even relatively large numbers of
chick embryo brains (240) yield only small quantities of the active fraction
(0.02 mg of rp-HPLC fraction #7). Proton NMR studies, while non-
destructive~ require a minimum concentration of 0.2 mM protein (Gadian,
1982); with an estimated molecular weight of 1600 Da., 0.16 mg of
mitogen is needed. Larger isolations should permit purification to
homogeneity. Exhaustive enzymatic digestion assays employing proteases,
RNases, and DNases would then shed light on the biochemical nature of
CBGF and the existence of a potential inhibitor. FAB-MS and NMR would
yield molecular weight, sequence, and other structural information. Amino
acid analysis and Edman degradation would also be performed.
In addition, the potential role of CBGF as the trophic factor involved
in the nerve-dependent blastema cell proliferation phase of newt limb
regeneration requires further investigation. In the past, CBGF has been
shown to be a blastema cell mitogen in vitro (Carlone et al., 1987).
Moreover, a fraction partially purified from adult newt brain has
biochemical characteristics identical to those of CBGF derived from chick
embryo brains and is mitogenic for cultured blastema cells (Carlone and
Rathbone, 1985; Carlone et al., 1987). On the other hand, Rathbone and
his colleagues have not reported the status of GMP and AMP as mitogens in
nerve dependent blastema cell proliferation. In any case, CBGF, like all
candidates for the trophic factor, must meet the four criteria outlined by
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Brockes (1984): 1) it must be present in the blastema, 2) its level nlust
decrease following denervation of the blastema, 3) it must stimulate cell
division of 22/18 + cells, the blastema cell population which is dependent
on the nerve for proliferation, and 4) an antibody against the factor should
block its biological activity and prevent the mitogenic effects of the nerve,
thereby mimicking denervation. Only following such experimentation
could the role of CBGP in Urodele nerve dependent limb regeneration be
assessed and determined.
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Figure A 1. Anion Exchange HPLC Elution Profile
of P6-3 Fractionation.
An anion exchange column was used to separate the
concentrated Biogel P6-3 fraction into seven peaks, which
were individually collected. The fractions were eluted
with a gradient of 0.1 % 0.007 M KH2P04 and 0.007 M KCl
(pH 4.0) to 99.9% 0.25 M KH2P04 and 0.50 M KCI (pH 5.0)
in 20 minutes. (HPLC = high-performance liquid
chromatography)
A: The elution profile monitored at 256 nm.
B: The elution profile monitored at 229 nm.
e: The elution profile monitored at 280 nm.
B
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Figure A2. Effect of Anion Exchange HPLC Fractions #1, 2, and 3 on
3H-thymidine Incorporation in Cultured Chick Embryo
Brain Non-neuronal Cells.
Two twenty-four well plates were assayed per fraction,
represented by Plate A and Plate B. Due to the high salt
concentration of the anion exchange solutions, a salt
control corresponding to the KHzP04 and KCI content of
each fraction at every concentration assayed was also
tested. Data are presented as mean incorporation of 3H-
thymidine in cpm. n = 4 for each treatment. [HPLC =
high-performance liquid chromatography; cpm = counts
per minute; 1% = 1% fetal bovine serum (FBS); 10% =
10% FBS]
Statistically significant differences (p~O.05) are
represented by the following symbols over the
corresponding bar on the graph:
x = significantly different from 1% FBS control;
o = significantly different from corresponding salt control.
A: Results for anion exchange HPLC fraction #1.
Second subculture cells were used.
B: Results for anion exchange HPLC fraction #2.
Second subculture cells were used.
C: Results for anion exchange HPLC fraction #3. Third
subculture cells were used.
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Figure A3. Effect of Anion Exchange HPLC Fractions #4, 5, and 6 on
3H-thymidine Incorporation in Cultured Chick Embryo
Brain Non-neuronal Cells.
Two twenty-four well plates were assayed per fraction,
represented by Plate A and Plate B. Due to the high salt
concentration of the anion exchange solutions, a salt
control corresponding to the KHzP04 and KCI content of
each fraction at every concentration assayed was also
tested. Data are presented as mean incorporation of 3H-
thymidine in cpm. n = 4 for each treatment. [HPLC =
high-performance liquid chromatography; cpm = counts
per minute; 1% = 1% fetal bovine serum (FBS); 10% =
10% PBS]
Statistically significant differences (p~O.05) are
represented by the following symbols over the
corresponding bar on the graph:
x = significantly different from 1% FBS control;
o = significantly different from corresponding salt control.
A: Results for anion exchange HPLC fraction #4. Third
subculture cells were used.
B: Results for anion exchange HPLC fraction #5. Third
subculture cells were used.
C: Results for anion exchange HPLC fraction #6.
Fourth subculture cells were used.
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Figure A4. Effect of Anion Exchange HPLC Fraction #7 on 3H-
thymidine Incorporation in Cultured Chick Embryo Brain
Non-neuronal Cells.
Two twenty-four well plates were assayed, represented
by Plate A and Plate B. Due to the high salt concentration
of the anion exchange solutions, a salt control
corresponding to the KHzP04 and KCI content of this
fraction at every concentration assayed was also tested.
Data are presented as mean incorporation of 3H-
thymidine in cpm. n = 4 for each treatment. Fourth
subculture cells were used. [HPLC = high-performance
liquid chromatography; cpm = counts per minute; 1% =
1% fetal bovine serum (FBS); 10% = 10% FBS]
Statistically significant differences (p~0.05) are
represented by the following symbol over the
corresponding bar on the graph:
x = significantly different from 1% FBS control.
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Table BI. Raw Data for Bioassays Giving 10% FBS and 1% FBS Results
(Mean + Standard Deviation)
Figure Number Plate 10% FBS 1% FBS
1 A 6068.7 ± 657.1 1180.2 ± 36.5
B 3247.5 ± 935.7 641.1 ± 77.5
6 7597.3 ± 1340.6 3498.0 ± 654.7
7 A 11544.4 ± 970.44 6387.6 ± 336.3
B 11480.2 ± 1004.1 6075.9 ± 1520.0
9 A 16223.6 ± 1311.8 9827.0 ± 1823.8
B 13529.3 ± 2416.7 6235.7 ± 345.4
10 A 13431.0 ± 3134.8 4922.7 ± 395.3
B 10473.2 ± 610.0 4900.3 ± 304.9
11 6783.5 ± 447.2 3971.8 ± 400.0
14 A 7920.2 ± 236.8 3625.6 ± 754.9
B 4688.1 ± 574.0 2823.0 ± 99.08
C 6774.4 ± 839.3 3685.1 ± 378.4
15 A 8361.7 ± 576.0 4255.9 ± 213.98
B 8988.9 ± 838.5 5783.7 ± 764.9
C 7729.4 ± 1139.6 5312.8 ± 683.7
16 A 6031.7 ± 1391.0 3756.0 ± 388.0
B 8306.6 ± 224.2 5362.7 ± 2253.6
C 7717.0 ± 518.3 5808.1 ± 231.3
17 A ·6875.7 ± 2373.9 5816.6 ± 442.2
B 6977.3 ± 1118.8 4330.4 ± 1183.8
24 A 8564.8 ± 398.7 4410.6 ± 331.9
B 7943.3 ± 1353.5 5023.6 ± 142.2
25 4717.8 ± 823.8 2019.1 ± 163.7
26 A 5987.3 ± 1283.2 1932.5 ± 38.90
B 7561.8 ± 792.8 3318.9 ± 314.4
27 3940.0 ± 1221.2 1429.3 ± 214.5
28 9767.7 ± 658.3 5045.1 ± 477.6
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